Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

C3_BREAST_ERNEG_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions not RX_ERPLUS	277748
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C50 Hospital discharge: ICD-9 — 174 Hospital discharge: ICD-8 — 174 Cause of death: ICD-10 — C50 Cause of death: ICD-9 — 174 Cause of death: ICD-8 — 174 Cancer registry: Topography ICD-O-3 — C50 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — [23] 3 out of 7 registries used, show all original rules.	10033
4. Check minimum number of events None	10033
5. Include endpoints None	10033
6. Filter based on genotype QC (FinnGen only)	10033

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE_EXALLC
Control conditions: not RX_ERPLUS

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BREAST_ERNEG_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE_EXALLC
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS	!RX_ERPLUS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS	!RX_ERPLUS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C50
HD_ICD_9	174
HD_ICD_8	174
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C50
COD_ICD_9	174
COD_ICD_8	174
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C50
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	[23]

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of breast, HER-negative

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	10033	10033	-
Unadjusted period prevalence (%)	3.42	3.42	-
Median age at first event (years)	58.38	58.38	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8753: Matched controls
85379

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

61.2

323.0

586

100

115

Kela drug reimbursment

Breast cancer

+∞

323.0

3292

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

4503599627370496.0

323.0

3439

L03AA13

ATC

pegfilgrastim; parenteral

2764.6

323.0

1047

PJA12

NOMESCO Finland

Sentinel node biopsy

5713.7

323.0

4604

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

1376.6

323.0

773

X76

ICPC

Malignant neoplasm breast female

1591.3

323.0

735

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

323.0

1063

A04AA55

ATC

palonosetron, combinations; systemic

+∞

323.0

1135

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

323.0

343

XX1XN

NOMESCO Finland

Other isotope examination

1190.5

323.0

463

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

5004.0

323.0

495

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

323.0

445

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

323.0

1132

WZC30

NOMESCO Finland

Teaching

4.7

323.0

1632

3932

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

180.4

323.0

389

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

110.1

323.0

1672

183

HA1AA

NOMESCO Finland

X-ray mammography

24.8

323.0

2893

1667

C50

ICD-10 Finland

Malignant neoplasm of breast

3153.3

323.0

1171

L02BG04

ATC

letrozole; oral

43.9

323.0

742

180

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

323.0

736

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

823.1

323.0

1868

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

323.0

663

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

323.0

463

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

323.0

933

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

323.0

3510

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

570.3

323.0

1670

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

3.9

323.0

3909

14656

A04AD12

ATC

aprepitant; systemic

1500.6

323.0

432

H02AB02

ATC

dexamethasone; systemic

78.6

323.0

2382

404

Z31.5

ICD-10 Finland

Genetic counselling

8.0

323.0

927

1243

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2976.3

323.0

591

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

323.0

453

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

323.0

474

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

323.0

450

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

323.0

809

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

399.4

323.0

356

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

323.0

312

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2410.4

323.0

1137

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

113.4

323.0

535

N63

ICD-10 Finland

Unspecified lump in breast

6.5

323.0

1455

2534

HAB40

NOMESCO Finland

Wedge excision of mammary gland

246.5

323.0

3239

203

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

5358.1

323.0

2772

NK6AN

NOMESCO Finland

Total body bone isotope imaging

73.0

323.0

462

A03FA01

ATC

metoclopramide; systemic, rectal

6.1

323.0

3243

7492

A04AA01

ATC

ondansetron; systemic, rectal

10.2

323.0

929

986

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

1006.5

323.0

1087

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

26.6

323.0

2453

1230

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

5884.4

323.0

1083

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

629.3

323.0

603

WF002

NOMESCO Finland

Radical radiotherapy

67.0

323.0

413

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

6828.7

323.0

659

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

2104.8

323.0

431

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

323.0

677

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

323.0

379

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

319

HAB99

NOMESCO Finland

Other partial excision of mammary gland

33.9

323.0

987

319

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

323.0

1522

JN4BD

NOMESCO Finland

Extensive body CT

6.3

323.0

946

1603

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

323.0

1249

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

126.8

323.0

782

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

41.2

323.0

815

212

WX402

NOMESCO Finland

General anaesthesia

3.9

323.0

2005

6019

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

6052.1

323.0

590

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

434.1

323.0

739

L03AA14

ATC

lipegfilgrastim; parenteral

5552.6

323.0

545

A04AA02

ATC

granisetron; systemic, transdermal

382.0

323.0

1204

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

168.1

323.0

473

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.7

323.0

2734

9431

HAC20

NOMESCO Finland

Total mastectomy

1545.6

323.0

2155

TQW20

NOMESCO Finland

Tatoe

238.3

323.0

485

C50.99

ICD-10 Finland

Breast, unspecified

16384.0

323.0

1506

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

4596.8

323.0

1599

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

68.6

323.0

1231

203

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

13.9

323.0

838

644

L01BC06

ATC

capecitabine; oral

+∞

323.0

602

ZX090

NOMESCO Finland

Other technic of radiotherapy

471.8

323.0

590

XX3DW

NOMESCO Finland

Time consuming IT work

14.5

323.0

2118

1836

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

3676.5

323.0

1610

ZX080

NOMESCO Finland

Image guided radiotherapy

1210.2

323.0

687

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

197.6

323.0

369

WF003

NOMESCO Finland

Adjuvant radiotherapy

565.5

323.0

697

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

38.6

323.0

469

125

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

361.7

323.0

427

L03AA02

ATC

filgrastim; parenteral

116.0

313.5

343

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

18.3

312.2

500

282

L02BA01

ATC

tamoxifen; oral

290.3

306.6

314

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1476.8

294.4

288

130

Kela drug reimbursment

Malignant tumour

+∞

292.7

282

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

99.7

292.3

325

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

286.4

276

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

57.8

285.5

342

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

282.2

272

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

932.0

282.1

278

HAE99

NOMESCO Finland

Other reconstruction of breast

83.9

277.5

315

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

6.3

274.6

790

1332

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

59.0

263.9

315

JN4AD

NOMESCO Finland

Body CT examination

7.0

255.3

672

1001

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

248.9

240

WF049

NOMESCO Finland

Radiotherapy of metastasis

817.9

247.8

245

ZZR10

NOMESCO Finland

Flap of skin and muscle

127.9

246.3

267

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

244.7

236

R4110

NOMESCO Finland

Physiotherapy

2.4

236.8

2741

13848

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

233.2

225

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

6.8

230.7

622

955

HA4ST

NOMESCO Finland

Labeling mammary gland pathology with sterotactic guidance

142.1

224.4

241

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

217.6

210

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

160.8

211.6

225

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

694.4

210.5

209

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

421.3

210.3

212

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

19.4

206.8

323

168

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

258.9

200.8

207

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

199.9

193

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

198.9

192

HAC25

NOMESCO Finland

Radical mastectomy

+∞

197.8

191

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

195.7

189

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

194.7

188

Z51.0

ICD-10 Finland

Radiotherapy session

481.6

193.3

194

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

37.3

191.3

249

9703

FHL

Breast resection

14.3

190.2

334

236

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

7.7

188.1

461

613

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

41.6

183.4

233

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

183.3

177

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

602.4

182.6

182

1CD02

NOMESCO Finland

+∞

182.2

176

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

181.2

175

TQB05

NOMESCO Finland

Puncture of skin of trunk

40.4

179.9

230

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

109.0

169.0

186

ZX070

NOMESCO Finland

Intensity modified radiotherapy

192.3

165.8

174

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

63.7

163.0

192

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

161.5

156

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

158.3

153

D70.82

ICD-10 Finland

Drug-induced neutropenia

28.2

158.1

220

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

269.2

157.5

162

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

129.2

156.1

169

8010/3-C50.9

ICD-O-3

Carcinoma, NOS, of breast, NOS

+∞

154.2

149

ZZF00

NOMESCO Finland

Graft of adipose tissue

26.0

151.9

216

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

40.7

150.5

192

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

372.0

149.1

151

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

149.0

144

5702

FHL

Local lymph node removal (eg armpit, groin)

83.6

148.1

168

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

146.9

142

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

145.9

141

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

145.9

141

HAD99

NOMESCO Finland

Other plastic operation on breast

34.3

145.8

193

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

361.9

145.0

147

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

26.0

141.4

201

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

24.9

139.0

200

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

5.5

138.9

434

797

9706

FHL

Ablation mammae, includes axillary exploration

1347.8

137.6

135

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

1336.1

136.5

134

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

135.5

131

ZX112

NOMESCO Finland

Subcutaneous

12.6

135.3

250

198

ZX120

NOMESCO Finland

Intravenous

3.1

133.5

813

2734

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

131.4

127

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

131.4

127

C50.2

ICD-10 Finland

Malignant neoplasm: Upper-inner quadrant of breast

+∞

129.3

125

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

127.6

2182

12403

1749X

ICD-9 Finland

Malignant neoplasm of female breast, Breast (female), unspecified

+∞

126.2

122

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

164.6

125.4

133

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

50.2

124.3

152

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

212.7

123.8

129

WX702

NOMESCO Finland

Supraglottic ventilation device

3.6

123.6

609

1745

D05.0

ICD-10 Finland

Lobular carcinoma in situ

249.5

122.1

126

HAD40

NOMESCO Finland

Mastopexy

30.5

122.0

166

HA4MT

NOMESCO Finland

Labeling mammary gland pathology with X-ray guidance

79.9

120.2

137

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

119.9

116

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

139.6

118.2

127

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

117.9

114

Z51.5

ICD-10 Finland

Palliative care

6.0

117.6

342

574

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

116.8

113

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

116.8

113

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

1115.3

114.8

113

HA6HA

NOMESCO Finland

Tomosynthesis assessment of mammary gland specimen

288.4

113.2

116

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

111.7

108

HA1HA

NOMESCO Finland

Tomosynthesis mammography

32.6

110.7

148

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

109.6

106

HAD60

NOMESCO Finland

Replacement of prosthetic implant in breast

127.4

107.1

116

XX1AD

NOMESCO Finland

Other CT-examination

217.2

105.8

110

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

43.5

105.2

132

HA3ST

NOMESCO Finland

Removal of lesion of breast with radiological guidance

30.6

104.6

142

HWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of mammary gland

53.3

102.6

124

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

102.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

336.1

101.3

103

X21

ICPC

Breast sympt/compl female other

5.4

101.1

322

603

ZXA05

NOMESCO Finland

Left side

1.8

100.4

2369

14819

128

Kela drug reimbursment

Cancers of female genital organs

332.7

100.3

102

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

98.2

HA1SA

NOMESCO Finland

Expansion mammography

49.0

97.0

119

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.2

96.5

560

1807

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

935.4

96.2

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

94.0

PJW99

NOMESCO Finland

Other operation on lymphatic system

461.2

93.6

1XC03

NOMESCO Finland

456.2

92.6

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

895.5

92.1

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

92.0

HA2AT

NOMESCO Finland

Cytology of mammary gland with ultrasound guidance

32.6

91.4

122

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

90.9

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

90.9

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

90.9

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

90.9

WF004

NOMESCO Finland

Palliative radiotherapy

231.6

90.8

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

89.9

L01CA04

ATC

vinorelbine; systemic

+∞

89.9

HAD50

NOMESCO Finland

Removal of prosthetic implant from breast

22.9

89.9

132

HAC10

NOMESCO Finland

Subcutaneous mastectomy with preservation of mamilla

95.7

87.1

1748X

ICD-9 Finland

Malignant neoplasm of female breast, Other specified sites of female breast

+∞

86.8

B01AB05

ATC

enoxaparin; parenteral

1.7

86.4

2525

16679

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

85.6

651

2498

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

3.3

84.9

465

1438

WB610

NOMESCO Finland

Demanding neoadjuvant therapy of tumour with antibodies

+∞

84.7

A79

ICPC

Malignancy NOS

65.0

84.6

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

61.0

83.8

8500/2-C50.4

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast

+∞

83.7

B01AB10

ATC

tinzaparin; parenteral

3.0

82.9

524

1789

ZXA00

NOMESCO Finland

Right side

1.7

82.9

2444

16144

8520/2-C50.9

ICD-O-3

Lobular carcinoma in situ, NOS, of breast, NOS

+∞

82.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

81.0

3333

23980

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

78.5

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

78.5

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

77.5

8510/3-C50.9

ICD-O-3

Medullary carcinoma, NOS, of breast, NOS

+∞

77.5

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

77.5

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

76.4

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.3

75.4

745

3284

N02BE01

ATC

paracetamol; systemic, rectal

1.8

75.2

7556

66797

HA1S1

NOMESCO Finland

Photography of breasts

371.4

75.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

8.0

74.8

176

219

JN4CD

NOMESCO Finland

Very extensive body CT

5.3

74.4

237

444

X19

ICPC

Breast lump/mass female

5.2

74.3

242

465

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

45.6

71.0

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

69.2

N02AA05

ATC

oxycodone; systemic

2.0

68.7

990

5135

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

67.1

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

80.9

65.3

L02BG06

ATC

exemestane; oral

+∞

65.1

D24

ICD-10 Finland

Benign neoplasm of breast

3.8

65.0

291

766

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

18.8

64.7

101

N64.9

ICD-10 Finland

Disorder of breast, unspecified

5.9

64.1

186

312

C50.3

ICD-10 Finland

Malignant neoplasm: Lower-inner quadrant of breast

+∞

64.0

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

9.0

63.7

139

153

ZZR00

NOMESCO Finland

Flap of skin

11.6

63.1

120

102

HAA10

NOMESCO Finland

Biopsy of mammary gland

7.1

63.0

160

224

8503/2-C50.9

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of breast, NOS

+∞

62.0

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

61.7

860

4394

R50.9

ICD-10 Finland

Fever, unspecified

2.0

61.4

914

4789

8140/3-C50.9

ICD-O-3

Adenocarcinoma, NOS, of breast, NOS

+∞

60.9

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

38.4

60.9

WW500

NOMESCO Finland

Blood transfusion

4.1

59.1

240

579

N64.5

ICD-10 Finland

Other signs and symptoms in breast

3.3

58.2

307

922

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

57.8

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

291.7

57.8

TQW99

NOMESCO Finland

Other minor procedure on skin

2.9

57.7

374

1294

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

286.6

56.7

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

64.8

56.6

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

56.1

3254

24646

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

144.8

55.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

54.7

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

+∞

54.7

17409

ICD-8 Finland

Malignant neoplasm of breast, Unspecified

+∞

54.7

9725

FHL

Reconstruction of the mammary gland with foreign material (after removal)

39.8

54.4

XX9TE

NOMESCO Finland

Compementary ultrasound examination

9.8

54.0

112

113

1743A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-inner quadrant

+∞

53.7

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

53.7

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

518.2

53.0

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

52.7

C50.09

ICD-10 Finland

Malignant tumor of nipple and areola, other or undeterminated histology

+∞

50.6

ZSZ00

NOMESCO Finland

Primary repair operation

173.3

50.4

9702

FHL

Breast exploration and possible tumor removal

3.4

49.7

252

735

HA1AE

SPAT

3.9

49.7

212

536

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

48.5

1741A

ICD-9 Finland

Malignant neoplasm of female breast, Central portion

+∞

48.5

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

44.5

47.6

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

240.2

47.6

8520/3-C50.2

ICD-O-3

Lobular carcinoma, NOS, of upper-inner quadrant of breast

+∞

47.5

S18

ICPC

Laceration/cut

1.4

47.2

3122

24012

L02BG03

ATC

anastrozole; oral

458.8

46.9

X26

ICPC

Fear of breast cancer female

7.3

46.5

115

156

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.2

46.0

149

286

PJA10

NOMESCO Finland

Exploration of lymph nodes

8.7

45.6

101

115

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.0

45.4

189

468

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

39.9

45.1

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

439.0

44.8

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.1

44.2

178

427

A02BC02

ATC

pantoprazole; systemic

1.4

43.8

5452

46529

N05CB02

ATC

barbiturates in combination with other drugs

2.5

43.8

366

1471

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

220.5

43.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

43.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

419.2

42.8

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

42.7

202

558

9719

FHL

Other measure in this category

16.0

42.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

42.3

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

41.8

603

3106

3AA13

NOMESCO Finland

409.3

41.8

JN6AD

NOMESCO Finland

CT of torso and neck

11.8

41.7

WX110

NOMESCO Finland

Local anesthesy

1.4

41.5

5287

45072

8522/3-C50.4

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-outer quadrant of breast

+∞

41.3

8000/3-C50.9

ICD-O-3

Neoplasm, malignant of breast, NOS

+∞

41.3

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

205.7

40.5

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

205.7

40.5

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

205.7

40.5

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

88.3

40.3

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

107.8

40.3

QBE30

NOMESCO Finland

Excision and repair of surgical scar in trunk

8.2

40.0

109

HA1BA

NOMESCO Finland

Extensive X-ray mammography

8.4

39.9

106

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.3

39.9

403

1785

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

200.8

39.5

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

39.2

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

39.2

D05

ICD-10 Finland

Carcinoma in situ of breast

+∞

39.2

HAD00

NOMESCO Finland

Augmentation mammoplasty

42.7

38.6

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

195.9

38.4

WB321

NOMESCO Finland

Multiple adjuvant therapy of malignancy with biomodifiers

+∞

38.2

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

38.2

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

38.2

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.6

38.1

284

1071

N60.8

ICD-10 Finland

Other benign mammary dysplasias

8.2

37.3

102

HA1ST

NOMESCO Finland

Biopsy of mammary gland with sterotactic guidance

23.0

37.3

8211/3-C50.9

ICD-O-3

Tubular adenocarcinoma of breast, NOS

+∞

37.2

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

38.4

37.0

HA1DA

NOMESCO Finland

Restricted mammography

33.6

36.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

359.9

36.7

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

36.1

XX1XT

NOMESCO Finland

Other puncture with other radiological guidance

19.3

35.9

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

4.1

34.9

142

346

2330A

ICD-9 Finland

Carcinoma in situ of breast and genito-urinary system, Breast

340.1

34.6

A04AA03

ATC

tropisetron; systemic

76.5

34.4

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

10.4

34.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

45.7

34.2

8520/3-C50.5

ICD-O-3

Lobular carcinoma, NOS, of lower-outer quadrant of breast

+∞

34.1

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

33.8

1361

9380

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.8

33.7

223

786

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

1.9

33.4

492

2550

C50.0

ICD-10 Finland

Malignant neoplasm: Nipple and areola

+∞

33.0

156

Kela drug reimbursment

Lapatinib

+∞

33.0

8520/3-C50.1

ICD-O-3

Lobular carcinoma, NOS, of central portion of breast

+∞

33.0

R92

ICD-10 Finland

Abnormal findings on diagnostic imaging of breast

6.8

32.8

121

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

320.3

32.6

C56

ICD-10 Finland

Malignant neoplasm of ovary

114.2

32.3

9721

FHL

Mamilla reconstruction or transposition

36.5

32.0

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

31.9

537

2919

QBJ00

NOMESCO Finland

Liposuction in trunk

6.6

31.8

123

HAD20

NOMESCO Finland

Liposuction of breast

20.9

31.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

33.5

31.4

OAA41

NOMESCO Finland

Health check based on individual needs

161.5

31.4

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.3

31.3

302

1308

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

2.8

31.2

207

731

QBA00

NOMESCO Finland

Puncture of skin of trunk

9.4

31.1

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

31.0

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

31.0

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

31.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

31.0

XX2VW

NOMESCO Finland

Radiologic consultation

6.9

30.8

111

9724

FHL

Breast augmentation or reconstruction with own tissue

27.4

30.6

C90.0

ICD-10 Finland

Multiple myeloma

107.7

30.3

N61

ICD-10 Finland

Inflammatory disorders of breast

2.9

30.2

191

654

2393A

ICD-9 Finland

Neoplasm of unspecified nature, Breast

5.6

30.1

159

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

21.6

30.0

L01XE07

ATC

[U] lapatinib; oral

+∞

29.9

N62

ICD-10 Finland

Hypertrophy of breast

2.0

29.9

384

1888

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.1

29.8

185

N06AX16

ATC

venlafaxine; oral

1.5

29.8

1037

6906

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.8

29.2

540

3029

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

28.9

8500/2-C50.5

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-outer quadrant of breast

+∞

28.9

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

28.9

1740A

ICD-9 Finland

Malignant neoplasm of female breast, Nipple and areola

+∞

28.9

L02AE02

ATC

leuprorelin; implant, parenteral

4.5

28.8

105

231

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

7.0

28.8

101

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

285.6

28.5

9708

FHL

Radical mastectomy (Halsted), also involves removal of the parasternal gland

285.6

28.5

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

8.0

28.3

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

42.8

28.3

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

22.3

28.3

HA1RA

SPAT

2.2

28.2

287

1275

SPAT1324

SPAT

Screening procedure

0.7

28.1

913

12502

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

30.2

27.7

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

141.9

27.3

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

27.9

27.2

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

52.2

26.8

XX2ET

NOMESCO Finland

+∞

26.8

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

26.8

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

26.8

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

26.8

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

26.8

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

265.1

26.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

31.1

26.5

GD1AD

NOMESCO Finland

Thorax CT examination

2.4

26.1

232

966

M05BA02

ATC

clodronic acid; systemic

33.3

26.1

J01MA12

ATC

levofloxacin; systemic

1.5

26.1

1152

8056

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

28.5

25.9

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

25.8

WB131

NOMESCO Finland

Very demanding neoadjuvant cytostatic therapy

+∞

25.8

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

25.8

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.3

25.7

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

25.5

566

3355

Z31.6

ICD-10 Finland

General counselling and advice on procreation

7.7

25.3

S77

ICPC

Malignant neoplasm of skin

14.7

25.1

N60.9

ICD-10 Finland

Benign mammary dysplasia, unspecified

5.0

25.1

162

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

25.0

443

2445

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

24.9

468

2637

8211/3-C50.4

ICD-O-3

Tubular adenocarcinoma of upper-outer quadrant of breast

+∞

24.8

1XC13

NOMESCO Finland

+∞

24.8

8523/3-C50.9

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of breast, NOS

+∞

24.8

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

24.8

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

24.8

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

24.8

8523/3-C50.4

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of upper-outer quadrant of breast

+∞

24.8

J01DB01

ATC

cefalexin; oral

1.3

24.3

6473

58606

SPAT1269

SPAT

Other puncture and/or drainage

6.6

23.9

8520/3-C50.8

ICD-O-3

Lobular carcinoma, NOS, of overlapping lesion of breast

+∞

23.7

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

23.7

1501

Kela drug reimbursment

Palbociclib

+∞

23.7

394

Kela drug reimbursment

Palbociclib

+∞

23.7

8500/2-C50.3

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of lower-inner quadrant of breast

+∞

23.7

C49.39

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor

+∞

23.7

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

23.7

8500/2-C50.2

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of upper-inner quadrant of breast

+∞

23.7

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

23.3

297

1457

L57.0

ICD-10 Finland

Actinic keratosis

1.6

23.3

585

3585

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

23.2

178

687

JAL30

NOMESCO Finland

Omentectomy

5.3

23.1

131

C507

ICD-10 Finland

+∞

22.7

8543/3-C50.9

ICD-O-3

Paget disease and intraductal carcinoma of breast of breast, NOS

+∞

22.7

PJ5YQ

NOMESCO Finland

+∞

22.7

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

22.7

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

224.8

22.4

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

224.8

22.4

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

224.8

22.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

224.8

22.4

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

44.0

22.1

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.7

21.7

151

552

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

4.5

21.7

167

N64.8

ICD-10 Finland

Other specified disorders of breast

4.9

21.4

143

ZSZ10

NOMESCO Finland

Secondary repair operation

78.3

21.4

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

112.4

21.3

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

112.4

21.3

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

21.2

196

834

HAD55

NOMESCO Finland

Incision of periprosthetic capsule of breast

48.9

20.8

8480/3-C50.4

ICD-O-3

Mucinous adenocarcinoma of upper-outer quadrant of breast

+∞

20.6

8401/3-C50.9

ICD-O-3

Apocrine adenocarcinoma of breast, NOS

+∞

20.6

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

20.6

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

20.6

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

20.6

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

20.6

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

20.6

8575/3-C50.9

ICD-O-3

Metaplastic carcinoma, NOS, of breast, NOS

+∞

20.6

C50.61

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, ductal tumor

+∞

20.6

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

20.4

164

650

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

20.4

183

770

A46

ICD-10 Finland

Erysipelas

1.5

20.4

835

5738

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.0

20.3

ZSP00

NOMESCO Finland

Procedure related to previous procedure classified in chapter P

107.6

20.3

M05BX04

ATC

denosumab; parenteral

1.7

20.2

405

2328

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.7

20.1

484

7042

Y83.4

ICD-10 Finland

Other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

13.9

20.0

WX704

NOMESCO Finland

Intubation

1.7

19.9

433

2548

WF099

NOMESCO Finland

Other radiotherapy

10.6

19.7

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

19.7

492

3012

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

19.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

19.6

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

19.6

ZZQ70

NOMESCO Finland

Free microvascular graft of lymph nodes

+∞

19.6

8530/3-C50.9

ICD-O-3

Inflammatory carcinoma of breast, NOS

+∞

19.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

19.6

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

19.6

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

19.6

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.6

19.5

100

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

19.5

526

3285

DHB00

NOMESCO Finland

Excision of lesion of external nose

8.0

19.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

102.7

19.3

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.7

19.2

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

19.1

173

729

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

18.7

107

345

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

53.7

18.7

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.6

18.7

135

504

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

18.6

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

18.6

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

18.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

18.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

18.6

8211/3-C50.2

ICD-O-3

Tubular adenocarcinoma of upper-inner quadrant of breast

+∞

18.6

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.8

18.5

305

1648

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

18.4

180

789

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

18.3

125

452

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

37.5

18.3

HAD10

NOMESCO Finland

Augmentation of breast using prosthesis

6.5

18.1

HAB30

NOMESCO Finland

Excision of mamilla or areola

29.3

18.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

17.9

483

3016

N05CF01

ATC

zopiclone; oral

1.2

17.6

2555

21223

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

17.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

17.5

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

17.5

8401/3-C50.4

ICD-O-3

Apocrine adenocarcinoma of upper-outer quadrant of breast

+∞

17.5

8097/3-C44.3

ICD-O-3

Basal cell carcinoma, nodular of skin of other and unspecified parts of face

+∞

17.5

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

17.5

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

65.1

17.5

R18

ICD-10 Finland

Ascites

3.4

17.4

246

SPAT1153

SPAT

Removal of sutures

1.3

17.3

2224

18203

QWF00

NOMESCO Finland

Reoperation for insufficiency of suture in plastic surgery of skin

175.9

17.3

HAF00

NOMESCO Finland

Excision of local recurrence of breast cancer

175.9

17.3

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.6

17.2

208

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.8

17.2

184

X79

ICPC

Benign neoplasm breast female

16.5

17.1

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

41.0

17.1

X77

ICPC

Malignant neopl genital female other

41.0

17.1

6117B

ICD-9 Finland

Other disorders of breast, Signs and symptoms in breast[TUMOR MAMMAE]

3.6

17.0

205

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

16.9

106

367

103

Kela drug reimbursment

Diabetes, insulin-treated

0.8

16.8

1141

14061

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.4

16.6

139

564

B29

ICPC

Lymph/immune mech sympt/complt other

6.0

16.5

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

16.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

16.5

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

16.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

16.5

8510/3-C50.4

ICD-O-3

Medullary carcinoma, NOS, of upper-outer quadrant of breast

+∞

16.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

16.5

335

Kela drug reimbursment

Lapatinib

+∞

16.5

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

16.5

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

16.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

16.5

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.5

16.5

601

4028

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.0

16.5

303

ZXC90

NOMESCO Finland

Use of absorbable mesh in surgery

166.1

16.3

QBA10

NOMESCO Finland

Incision of skin of trunk

3.7

16.2

184

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.4

16.2

HA1AT

SPAT

13.0

16.2

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.8

16.2

1018

12677

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

39.0

16.1

A21

ICPC

Risk factor for malignancy

39.0

16.1

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

6.0

16.1

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

16.0

376

2266

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.4

16.0

227

ZQZ00

NOMESCO Finland

Treatment of several skin areas

8.2

15.8

HA5CB

NOMESCO Finland

Galactography

6.5

15.6

ZZS50

NOMESCO Finland

Insertion of tissue expander

58.6

15.6

8575/3-C50.4

ICD-O-3

Metaplastic carcinoma, NOS, of upper-outer quadrant of breast

+∞

15.5

WB600

NOMESCO Finland

Neoadjuvant therapy of primary tumour with antibodies

+∞

15.5

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

15.5

8507/3-C50.9

ICD-O-3

Invasive micropapillary carcinoma of breast of breast, NOS

+∞

15.5

8520/3-C50.3

ICD-O-3

Lobular carcinoma, NOS, of lower-inner quadrant of breast

+∞

15.5

8500/2-C50.1

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of central portion of breast

+∞

15.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

15.5

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

4.8

15.3

105

THA00

NOMESCO Finland

Needle biopsy of mamilla

9.5

15.3

ZZS55

NOMESCO Finland

Distension of tissue expander

156.3

15.3

PJ4AT

NOMESCO Finland

Labeling lymphnode with ultrasound guidance

156.3

15.3

WF001

NOMESCO Finland

Preoperative radiotherapy

156.3

15.3

PG1BD

NOMESCO Finland

Extensive CT angiography of tissue graft, e.g. assessment of TRAN graft

156.3

15.3

T85.4

ICD-10 Finland

Mechanical complication of breast prosthesis and implant

6.8

15.2

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

15.2

1331

10354

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.5

15.2

118

463

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.5

15.0

116

452

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

43.9

14.9

9729

FHL

Other measure in this category

5.1

14.8

HAB20

NOMESCO Finland

Excision of lactiferous duct

4.7

14.8

105

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

14.6

705

4991

JFB30

NOMESCO Finland

Right hemicolectomy

4.8

14.6

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

14.5

242

1318

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

14.4

JN5AN

NOMESCO Finland

Total body isotope imaging

+∞

14.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

14.4

9020/3-C50.9

ICD-O-3

Phyllodes tumor, malignant of breast, NOS

+∞

14.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

14.4

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

14.4

1930A

ICD-9 Finland

Malignant neoplasm of thyroid gland[CARCINOMA PAPILLARE THYREOIDEAE]

+∞

14.4

C50.02

ICD-10 Finland

Malignant tumor of nipple and areola, lobular tumor

+∞

14.4

ZX050

NOMESCO Finland

Stereotactic radiotherapy

9.5

14.4

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

146.5

14.3

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

146.5

14.3

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

146.5

14.3

L01CB01

ATC

etoposide; systemic

146.5

14.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

146.5

14.3

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

14.3

515

6979

HA1DM

NOMESCO Finland

Mammary gland very extensive MRI examination with 3 Tesla magnet

26.5

14.1

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

26.5

14.1

A10BA02

ATC

metformin; oral

0.8

14.0

1252

14958

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

6.9

13.9

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

41.5

13.9

2170A

ICD-9 Finland

Benign neoplasm of breast[NEOPLASMA BENIGNUM MAMMAE]

3.0

13.8

248

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

13.8

121

506

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.5

13.7

176

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

2.3

13.7

126

540

R84

ICPC

Malignant neoplasm bronchus/lung

52.1

13.6

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.4

13.5

107

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

13.4

8522/3-C50.5

ICD-O-3

Infiltrating duct and lobular carcinoma of lower-outer quadrant of breast

+∞

13.4

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

13.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

13.4

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

13.4

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

13.4

8504/2-C50.9

ICD-O-3

Encapsulated papillary carcinoma of breast, NOS

+∞

13.4

8522/3-C50.2

ICD-O-3

Infiltrating duct and lobular carcinoma of upper-inner quadrant of breast

+∞

13.4

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

13.4

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

+∞

13.4

1CD01

NOMESCO Finland

+∞

13.4

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

13.4

1744A

ICD-10 Finland

+∞

13.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

136.7

13.3

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

136.7

13.3

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

13.3

973

7373

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

7.2

13.1

WW200

SPAT

0.7

13.1

379

5334

N05BA04

ATC

oxazepam; oral

1.2

13.1

1903

15718

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

4.5

13.0

TPX15

NOMESCO Finland

Removal of vascular injection port

8.3

13.0

-1

ICD-10 Finland

1.8

12.9

226

1251

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.1

12.7

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

48.8

12.7

SAA01

NOMESCO Finland

Simple examination of mouth

0.8

12.7

4647

48810

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

12.6

215

153

Kela drug reimbursment

Lenalidomid

68.2

12.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

68.2

12.4

SPAT1152

SPAT

Removal of foreign body from under the skin

1.9

12.4

185

969

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

12.4

477

3233

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.1

12.4

218

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.4

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

12.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

12.4

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

+∞

12.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

12.4

Z44.3

ICD-10 Finland

Fitting and adjustment of external breast prosthesis

+∞

12.4

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

12.4

L04AX04

ATC

lenalidomide; oral

+∞

12.4

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

12.4

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

+∞

12.4

L01EF01

ATC

palbociclib; oral

+∞

12.4

HAC99

NOMESCO Finland

Other mastectomy

+∞

12.4

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

127.0

12.3

QBE35

NOMESCO Finland

Repair of skin defect in trunk after surgery or injury

11.3

12.1

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

36.6

12.0

T90

ICPC

Diabetes non-insulin dependent

0.8

12.0

1006

12123

KCD02

NOMESCO Finland

Transurethral resection of bladder

5.8

11.9

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

11.8

7256

68082

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

11.8

108

464

HA1AA

SPAT

2.1

11.8

133

626

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

4.7

11.7

N81.1

ICD-10 Finland

Cystocele

0.7

11.6

444

5962

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

11.6

442

2992

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

11.5

3896

41327

ZXC96

NOMESCO Finland

Robot assisted procedure

3.1

11.5

197

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

29.3

11.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

63.4

11.5

N60.1

ICD-10 Finland

Diffuse cystic mastopathy

2.6

11.4

305

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

0.7

11.4

398

5428

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

7.5

11.4

C49.30

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the thorax without histology

+∞

11.3

9680/3-C50.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of breast, NOS

+∞

11.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

11.3

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

11.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

11.3

1XC14

NOMESCO Finland

+∞

11.3

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

11.3

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

11.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

11.3

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

11.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

11.3

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

11.3

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

11.3

C34.22

ICD-10 Finland

Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma

+∞

11.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

11.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

11.3

8543/3-C50.1

ICD-O-3

Paget disease and intraductal carcinoma of breast of central portion of breast

+∞

11.3

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.8

11.3

1004

12028

HAA01

NOMESCO Finland

Suture of mammary gland

117.2

11.3

ZX121

NOMESCO Finland

Central venous catheter

9.8

11.3

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

13.3

11.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

11.2

1700

14068

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.8

11.2

187

1021

ZZR70

NOMESCO Finland

Perforator flaps

34.2

11.1

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

34.2

11.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.1

11.0

125

590

QCJ00

NOMESCO Finland

Liposuction in upper limb

16.6

11.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

11.0

608

4407

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

42.3

10.8

ZZA50

NOMESCO Finland

Full thickness skin graft

9.0

10.8

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

5.0

10.7

X18

ICPC

Breast pain female

2.0

10.7

125

599

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

10.7

223

1308

QBJ99

NOMESCO Finland

Other aesthetic correction of skin of trunk

17.4

10.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

10.4

328

2133

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

10.3

444

3080

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

10.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

10.3

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

10.3

8507/3-C50.4

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-outer quadrant of breast

+∞

10.3

ZZQ60

NOMESCO Finland

Free microvascular graft of nerve

+∞

10.3

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

10.3

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

10.3

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

10.3

8524/3-C50.9

ICD-O-3

Infiltrating lobular mixed with other types of carcinoma of breast, NOS

+∞

10.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

10.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

10.3

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

10.3

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

10.3

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

10.3

C50.69

ICD-10 Finland

Malignant tumor of the scapula of the mammary gland, other or undeterminated histology

+∞

10.3

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

10.3

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

2.4

10.3

371

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

107.4

10.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

107.4

10.3

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

107.4

10.3

JAL00

NOMESCO Finland

Biopsy of peritoneum

5.3

10.3

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.7

10.2

286

4045

L02AE03

ATC

goserelin; implant

3.0

10.1

191

HAD57

NOMESCO Finland

Resection of periprosthetic capsule of breast

18.3

10.1

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

10.0

286

1820

GDC00

NOMESCO Finland

Lobectomy of lung

12.8

10.0

A26

ICPC

Fear of cancer, NOS

3.5

9.9

122

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.1

9.9

164

Z08

ICD-10 Finland

Follow-up examination after treatment for malignant neoplasms

39.0

9.8

ZXC82

NOMESCO Finland

Microsurgical

14.2

9.8

D75

ICPC

Malignant neoplasm colon/rectum

14.2

9.8

SFA10

NOMESCO Finland

Fillning on one surface of tooth

0.9

9.8

3212

34313

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

3.1

9.8

160

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

1.9

9.7

147

777

E66.01

ICD-10 Finland

Obesity due to excess calories

0.7

9.7

254

3637

C44

ICD-10 Finland

Other malignant neoplasms of skin

11.9

9.7

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

9.6

1270

10344

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

1.9

9.6

130

663

KAC10

NOMESCO Finland

Total nephrectomy with capsule

9.3

9.6

GA5AA

NOMESCO Finland

Rib X-ray examination

5.3

9.5

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

53.7

9.5

E34.0

ICD-10 Finland

Carcinoid syndrome

53.7

9.5

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

53.7

9.5

E0000UV

ATC

1.2

9.5

2858

25090

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.1

9.4

159

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

0.9

9.4

2903

31176

N81.6

ICD-10 Finland

Rectocele

0.7

9.4

445

5786

A06AH03

ATC

naloxegol; oral

4.5

9.4

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

9.4

207

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

0.9

9.3

3520

37276

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

97.7

9.3

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

97.7

9.3

9829

FHL

Other measure in this category

97.7

9.3

9710

FHL

Existence of a relapse

97.7

9.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

9.3

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

9.3

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

9.3

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

9.3

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

9.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

9.3

389

Kela drug reimbursment

Olaparib

+∞

9.3

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

9.3

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

9.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

9.3

8540/3-C50.0

ICD-O-3

Paget disease, mammary of nipple

+∞

9.3

C739

ICD-10 Finland

+∞

9.3

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

9.3

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

9.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

9.3

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

9.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

9.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

9.3

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.3

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

9.3

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

9.3

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

9.3

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

9.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

9.3

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

9.3

1511

Kela drug reimbursment

Olaparib

+∞

9.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

9.3

G47.3

ICD-10 Finland

Sleep apnoea

0.8

9.3

781

9425

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

9.3

257

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

9.1

155

853

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

9.1

729

5591

B01AB04

ATC

dalteparin; parenteral

1.5

9.1

287

1871

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.2

9.0

378

9705

FHL

Subcutaneous mastectomy

13.3

9.0

ZZA00

NOMESCO Finland

Split skin graft

1.9

8.9

120

610

XX9CN

NOMESCO Finland

35.8

8.9

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

35.8

8.9

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

15.2

8.9

L02AB02

ATC

medroxyprogesterone; systemic (progestogens)

3.2

8.9

134

A41.9

ICD-10 Finland

Sepsis, unspecified

1.8

8.8

151

835

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

23.4

8.8

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.7

8.7

370

4883

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.1

8.7

428

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

48.8

8.6

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

13.7

8.5

A87

ICPC

Complication of medical treatment

2.8

8.5

183

R06AE07

ATC

cetirizine; oral

1.1

8.4

3411

30532

E66.8

ICD-10 Finland

Other obesity

0.6

8.4

153

2359

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

8.4

232

1467

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

4.0

8.4

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

26.8

8.4

D77

ICPC

Malignant digestive neopl other/NOS

26.8

8.4

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.4

8.4

261

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

87.9

8.3

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

8.3

300

2012

9734

FHL

Excision and local plastic or associated free skin grafting

3.1

8.3

141

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

6.2

8.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

8.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

8.3

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

8.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

8.3

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

8.3

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

8.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

8.3

C44.99

ICD-10 Finland

Unspecified localization of malignant tumor in skin other or unspecified histology

+∞

8.3

8480/3-C50.3

ICD-O-3

Mucinous adenocarcinoma of lower-inner quadrant of breast

+∞

8.3

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

8.3

8097/3-C44.5

ICD-O-3

Basal cell carcinoma, nodular of skin of trunk

+∞

8.3

9120/3-C50.9

ICD-O-3

Hemangiosarcoma of breast, NOS

+∞

8.3

8500/2-C50.8

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of overlapping lesion of breast

+∞

8.3

1BC02

NOMESCO Finland

+∞

8.3

8501/2-C50.9

ICD-O-3

Comedocarcinoma, noninfiltrating of breast, NOS

+∞

8.3

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

8.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

8.3

1746A

ICD-9 Finland

Malignant neoplasm of female breast, Axillary tail

+∞

8.3

C69.32

ICD-10 Finland

Malignant tumor of the chorioidea melanoma

+∞

8.3

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

8.3

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

8.3

C85.7

ICD-10 Finland

Other specified types of non-Hodgkin lymphoma

+∞

8.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.0

8.2

104

518

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

10.5

8.1

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

3.6

8.1

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

8.1

465

5879

9722

FHL

Reduction plastic and possible mamilla transposition

3.3

8.1

112

KMAK

NOMESCO Finland

0.9

8.0

3177

33660

6101A

ICD-9 Finland

Benign mammary dysplasias, Diffuse cystic mastopathy

2.7

7.9

192

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.9

7.8

5006

51486

J05AB11

ATC

valaciclovir; oral

1.2

7.8

892

7144

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

7.7

669

5187

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

7.7

1276

14415

Y84.9

ICD-10 Finland

Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

7.7

TQX05

NOMESCO Finland

Skin puncture, unspecified location

5.0

7.6

N05AX08

ATC

risperidone; systemic

0.7

7.6

270

3667

C15.4

ICD-10 Finland

Malignant neoplasm: Middle third of oesophagus

43.9

7.6

WE198

NOMESCO Finland

Palliative cystotatic therapy

43.9

7.6

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.2

7.6

340

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.5

7.6

226

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.2

7.6

333

L03.3

ICD-10 Finland

Cellulitis of trunk

2.9

7.5

150

WX707

NOMESCO Finland

Fiberoscopic intubation

6.2

7.5

C10AA01

ATC

simvastatin; oral

0.9

7.5

2651

28333

G03DA02

ATC

medroxyprogesterone; systemic (pregnen (4) derivatives)

1.2

7.5

953

7727

EBA00

NOMESCO Finland

Extraction of tooth

0.9

7.5

1605

17769

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

1.6

7.5

186

1150

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

24.4

7.5

PJD99

NOMESCO Finland

Excision of other lymph nodes

24.4

7.5

C43

ICD-10 Finland

Malignant melanoma of skin

24.4

7.5

K02.1

ICD-10 Finland

Caries of dentine

0.9

7.5

3335

35111

SAA02

NOMESCO Finland

Basic examination of mouth

0.9

7.4

4135

42958

N60.0

ICD-10 Finland

Solitary cyst of breast

2.5

7.4

215

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.7

7.4

235

3246

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.9

7.4

1499

16665

9822

FHL

Myocutaneous graft

78.2

7.3

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

78.2

7.3

9844

FHL

Musculocutaneous tongue

78.2

7.3

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

78.2

7.3

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

78.2

7.3

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

3.4

7.3

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.3

7.3

263

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

1.5

7.3

239

1574

A08

ICPC

Swelling

1.5

7.3

271

1835

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

7.2

832

9725

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.7

7.2

140

810

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

7.2

117

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

7.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

7.2

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

7.2

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

7.2

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

7.2

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

+∞

7.2

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

+∞

7.2

18301

ICD-8 Finland

Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary

+∞

7.2

8523/3-C50.5

ICD-O-3

Infiltrating duct mixed with other types of carcinoma of lower-outer quadrant of breast

+∞

7.2

1XC07

NOMESCO Finland

+∞

7.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

7.2

8503/3-C50.4

ICD-O-3

Intraductal papillary adenocarcinoma with invasion of upper-outer quadrant of breast

+∞

7.2

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

7.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

7.2

8010/3-C50.4

ICD-O-3

Carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.2

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

7.2

4CJ01

NOMESCO Finland

+∞

7.2

CKE60

NOMESCO Finland

Brachytherapy of choroid and retina

+∞

7.2

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

7.2

HA1DT

NOMESCO Finland

Mammary gland biopsy with MRI guidance

+∞

7.2

L01EH01

ATC

lapatinib; oral

+∞

7.2

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.2

L01AX03

ATC

temozolomide; systemic

+∞

7.2

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

7.2

8200/3-C50.9

ICD-O-3

Adenoid cystic carcinoma of breast, NOS

+∞

7.2

8503/2-C50.4

ICD-O-3

Noninfiltrating intraductal papillary adenocarcinoma of upper-outer quadrant of breast

+∞

7.2

8480/3-C50.5

ICD-O-3

Mucinous adenocarcinoma of lower-outer quadrant of breast

+∞

7.2

8480/3-C50.2

ICD-O-3

Mucinous adenocarcinoma of upper-inner quadrant of breast

+∞

7.2

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

7.2

8509/2-C50.9

ICD-O-3

Solid papillary carcinoma in situ of breast, NOS

+∞

7.2

8070/3-C15.9

ICD-O-3

Squamous cell carcinoma, NOS, of esophagus, NOS

+∞

7.2

C51.81

ICD-10 Finland

Squamous cell carcinoma of the vulva

+∞

7.2

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.2

8070/3-C44.7

ICD-O-3

Squamous cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.2

TQW40

NOMESCO Finland

Remowal of suture of skin

1.3

7.2

420

3080

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

8.1

7.2

T80.8

ICD-10 Finland

Other complications following infusion, transfusion and therapeutic injection

10.6

7.2

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

15.3

7.1

JAH00

NOMESCO Finland

Laparotomy

1.8

7.1

111

598

SDA02

NOMESCO Finland

Parodonthologic therapy

0.9

7.1

1899

20691

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

29.3

7.1

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

29.3

7.1

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

0.7

7.1

248

3370

G56.0

ICD-10 Finland

Carpal tunnel syndrome

0.8

7.0

731

8633

JJB10

NOMESCO Finland

Atypcal resection of liver

19.5

7.0

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

3.1

7.0

109

XX9XW

NOMESCO Finland

3.2

7.0

104

L03

ICPC

Low back symptom/complaint

0.9

7.0

1421

15801

OAB47

SPAT

0.5

6.9

871

L91.0

ICD-10 Finland

Hypertrophic scar

2.2

6.9

302

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

9.8

6.9

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

6.9

249

1677

A14AB01

ATC

nandrolone; parenteral

4.4

6.9

N39.3

ICD-10 Finland

Stress incontinence

0.8

6.9

475

5864

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

6.8

QWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of skin

4.2

6.8

ZXA10

NOMESCO Finland

Bilateral

1.2

6.8

1338

11308

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

13.4

6.8

PD2BD

NOMESCO Finland

Extensive CT angiography of pelvic organs

13.4

6.8

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.3

6.8

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.7

6.7

293

3847

SDA01

NOMESCO Finland

Simple parodonthologic therapy

0.9

6.7

1341

14937

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

39.0

6.7

329

Kela drug reimbursment

Lenalidomide

39.0

6.7

XX1XW

NOMESCO Finland

Extensive written report from radiologist

1.8

6.7

520

A10AE04

ATC

insulin glargine; parenteral

0.7

6.7

264

3516

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.7

6.6

117

660

NK6SN

NOMESCO Finland

Bone SPECT

16.3

6.6

21899

ICD-8 Finland

Uterine fibroma

1.3

6.6

434

3239

P01BA02

ATC

hydroxychloroquine; oral

0.8

6.6

442

5483

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.9

6.6

513

SPAT1193

SPAT

Pap smear

0.8

6.6

401

5031

M01AC06

ATC

meloxicam; systemic, rectal

0.9

6.6

2617

27814

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

6.6

321

L88

ICPC

Rheumatoid/seropositive arthritis

0.7

6.6

148

2174

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.9

6.6

2671

28353

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

7.0

6.6

ZXC50

NOMESCO Finland

Cryotherapy

1.7

6.6

121

690

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

6.5

247

1678

205

Kela drug reimbursment

Chronic hypertension

0.9

6.5

1484

16372

ZXM40

NOMESCO Finland

Use of fluorescent substance

7.6

6.5

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

6.5

1553

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

11.9

6.5

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

9.8

6.4

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

6.4

878

10098

HA4GT

NOMESCO Finland

Labeling mammary gland pathology with galactographic guidance

3.8

6.4

C91.7

ICD-10 Finland

Other lymphoid leukaemia

68.2

6.4

WE100

NOMESCO Finland

Profylactic cytostatic therapy

68.2

6.4

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

68.2

6.4

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

68.2

6.4

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

6.3

972

8027

A07AA09

ATC

vancomycin; oral

2.0

6.3

370

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

6.3

359

2624

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

13.9

6.3

SPAT1310

SPAT

Counselling related to known health issue

0.9

6.3

1869

20243

N02AA01

ATC

morphine; systemic, rectal

2.6

6.2

152

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

1.6

6.2

155

962

JFF10

NOMESCO Finland

Loop enterostomy

4.5

6.2

L01XK01

ATC

olaparib; oral

+∞

6.2

L01EF03

ATC

abemaciclib; oral

+∞

6.2

8480/3-C50.1

ICD-O-3

Mucinous adenocarcinoma of central portion of breast

+∞

6.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.2

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

6.2

1515

Kela drug reimbursment

+∞

6.2

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

6.2

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

+∞

6.2

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

6.2

C18.51

ICD-10 Finland

Malignant tumor of flexura hiealis invasive carcinoma

+∞

6.2

8010/2-C50.9

ICD-O-3

Carcinoma in situ, NOS, of breast, NOS

+∞

6.2

8140/3-C16.9

ICD-O-3

Adenocarcinoma, NOS, of stomach, NOS

+∞

6.2

1DB03

NOMESCO Finland

+∞

6.2

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

6.2

C16.33

ICD-10 Finland

Malignant tumor of the antrum ventriculi diffuse carcinoma

+∞

6.2

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.2

8541/3-C50.9

ICD-O-3

Paget disease and infiltrating duct carcinoma of breast of breast, NOS

+∞

6.2

C18.10

ICD-10 Finland

Malignant tumor of the appendix without histology

+∞

6.2

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

8201/3-C50.4

ICD-O-3

Cribriform carcinoma, NOS, of upper-outer quadrant of breast

+∞

6.2

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

+∞

6.2

8522/3-C50.8

ICD-O-3

Infiltrating duct and lobular carcinoma of overlapping lesion of breast

+∞

6.2

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

6.2

3030

Kela drug reimbursment

Abemaciclib

+∞

6.2

L01XE01

ATC

[U] imatinib; oral

+∞

6.2

9680/3-C77.8

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions

+∞

6.2

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

6.2

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

6.2

8201/3-C50.9

ICD-O-3

Cribriform carcinoma, NOS, of breast, NOS

+∞

6.2

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

+∞

6.2

WC402

NOMESCO Finland

Demanding antibody therapy of local recurrence of tumour

+∞

6.2

8470/3-C56.9

ICD-O-3

Mucinous cystadenocarcinoma, NOS, of ovary

+∞

6.2

C49.19

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor

+∞

6.2

155

Kela drug reimbursment

Afatinib and gefitinib

+∞

6.2

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

6.2

173

Kela drug reimbursment

Trastuzumab injection

+∞

6.2

19399

ICD-8 Finland

Malignant neoplasm of thyroid gland

+∞

6.2

197

Kela drug reimbursment

Sunitinib

+∞

6.2

5BX04

NOMESCO Finland

+∞

6.2

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

+∞

6.2

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

6.2

3009

Kela drug reimbursment

Niraparib

+∞

6.2

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

6.2

BA1NN

NOMESCO Finland

I-131 dose capsel measurement

+∞

6.2

HA1CG

SPAT

+∞

6.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

6.2

9691/3-C77.9

ICD-O-3

Follicular lymphoma, grade 2 of lymph node, NOS

+∞

6.2

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

6.2

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

+∞

6.2

8507/3-C50.2

ICD-O-3

Invasive micropapillary carcinoma of breast of upper-inner quadrant of breast

+∞

6.2

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

6.2

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.2

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

6.2

159

Kela drug reimbursment

Pazopanib

+∞

6.2

8211/3-C50.5

ICD-O-3

Tubular adenocarcinoma of lower-outer quadrant of breast

+∞

6.2

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

6.2

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

1.8

6.2

521

MA5AE

NOMESCO Finland

Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation

0.3

6.1

341

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

2.6

6.1

148

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.7

6.1

161

2293

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.6

6.1

119

1798

N06AB05

ATC

paroxetine; oral

1.3

6.1

376

2787

C08CA01

ATC

amlodipine; oral

0.9

6.1

2103

22571

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

6.1

1001

11334

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

862

141

64.15

307.65

2.9

1.1

u/ml

32.4

22.0

1.45

852

131

(40768793) Breast Pathology biopsy report

2201

846

31.74

307.65

1.4

1.2

—

(40768804) Tissue Pathology biopsy report

5276

30031

2.45

307.65

2.4

1.7

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

6588

43070

2.37

307.65

10.6

6.5

e9/l

3.7

4.1

44.01

5732

36764

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

256

106

23.78

307.65

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

4175

21889

2.43

307.65

2.2

2.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

6507

38261

2.81

307.65

7.7

3.5

umol/l

9.8

10.5

5.05

6265

35426

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8424

61798

2.94

307.65

9.5

5.4

u/l

79.9

75.8

10.99

8085

56851

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1944

4569

4.83

307.65

3.2

1.5

ug/l

13.8

8.3

0.79

1428

3395

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5686

33446

2.46

307.65

3.7

3.5

—

(40768795) Lymph node Pathology biopsy report

434

167

26.05

307.65

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

757

491.48

307.65

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4768

27400

2.28

307.65

4.7

2.1

mmol/l

2.4

21.15

4282

22743

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1452

212

76.76

307.65

3.0

1.1

u/ml

29.8

28.6

0.06

1406

195

(4035726)

2774

2429

14.78

307.65

1.5

1.2

—

(3002256) Pathology report gross observation

2581

6754

4.60

307.65

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

582

144.69

307.65

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

655

1343

4.94

283.41

1.2

1.3

—

(40758558) Short blood count panel - Blood

3340

18270

2.13

251.89

7.6

4.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3055

16593

2.11

230.89

2.2

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1290

5664

2.36

158.67

1.7

2.0

g/l

0.2

9.69

1237

5147

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1074

4723

2.33

130.26

3.4

1.5

u/ml

83.8

27.7

1.32

1050

4495

(3023368) Bacteria identified in Blood by Culture

2799

17269

1.77

129.74

4.1

3.7

—

(3003694) ABO and Rh group [Type] in Blood

2798

17744

1.71

115.06

1.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5016

37049

1.60

111.51

5.1

4.6

mmol/l

1.2

1.74

4554

32605

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5465

41308

1.60

109.29

5.9

5.1

mmol/l

1.2

0.07

4557

34602

(3024561) Albumin [Mass/volume] in Serum or Plasma

4503

33470

1.53

89.92

4.0

3.5

g/l

35.5

35.9

5.14

4159

30367

(3033658) Prothrombin time (PT) actual/Normal

2689

18148

1.58

80.86

3.4

3.2

94.7

94.2

0.39

2641

17553

(3042936) Bacteria identified in Isolate by Culture

1556

9243

1.73

77.00

1.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1663

10848

1.57

54.98

2.9

2.2

mmol/l

0.8

0.77

1536

9804

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

7.60

53.68

6.1

1.5

—

(3018418) pH of Serum or Plasma

3282

24671

1.41

52.73

3.8

3.1

7.4

1.42

661

4093

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

215

722

2.90

44.81

1.3

nmol/l

0.3

0.4

0.36

142

534

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1686

11498

1.49

44.32

1.9

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1050

6534

1.61

41.60

4.2

2.8

u/l

250.7

241.2

1.29

977

6026

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

378

1720

2.15

41.14

2.9

1.9

u/ml

2429.1

159.3

0.76

331

1375

(3019225) pH of Specimen

1304

8632

1.52

39.15

3.9

3.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

8593

77387

1.47

37.60

16.0

11.0

ml/min/173m2

79.5

77.7

15.02

7455

61734

(3032080) INR in Blood by Coagulation assay

3734

29797

1.32

37.41

7.3

7.9

inr

1.3

1.2

0.19

1115

8371

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1141

7407

1.54

37.39

3.2

3.1

—

(40768806) Pleura Pathology biopsy report

125

342

3.54

36.61

1.4

1.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

5401

45483

1.30

35.98

4.1

3.8

mmol/l

6.5

6.6

7.59

5118

42074

(4281824)

175

594

2.86

35.84

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8349

84403

0.70

35.05

5.0

5.2

mmol/l

2.9

2.8

0.75

7436

77354

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8156

82703

0.72

33.77

4.4

4.7

mmol/l

4.9

4.36

7298

76090

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7616

78004

0.74

33.09

5.4

5.9

mmol/mol

39.2

39.6

4.23

6819

71617

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7751

79092

0.74

31.79

3.9

4.1

mmol/l

1.2

1.3

1.93

6823

71692

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8097

82041

0.73

31.19

4.4

4.6

mmol/l

1.6

7.39

7206

75091

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

697

4216

1.63

30.68

1.7

1.6

—

(42870588) Differential panel, method unspecified - Blood

3251

26129

1.29

28.72

5.1

5.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

149

525

2.75

28.55

1.3

1.4

g/l

32.5

28.9

2.84

134

448

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2074

15738

1.34

27.75

3.1

2.3

mmol/l

2.5

7.61

1829

13444

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

276

1299

2.07

27.57

1.6

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1146

7898

1.44

27.47

1.8

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1146

7902

1.44

27.39

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

286

1369

2.04

27.29

1.3

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

262

1237

2.06

25.97

1.6

1.4

—

(3002030) Lymphocytes/100 leukocytes in Blood

4437

37403

1.25

25.30

5.4

5.8

27.0

29.0

26.57

4079

34311

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

117

390

2.90

24.90

1.8

1.1

ug/l

1.6

2.5

4.12

303

(3012441) Differential panel - Pleural fluid

116

386

2.91

24.76

1.4

1.5

—

(3019069) Monocytes/100 leukocytes in Blood

4337

36546

1.25

24.54

5.5

6.0

8.7

8.3

8.79

4007

33712

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3011

24342

1.27

24.39

3.5

2.6

u/l

33.6

31.5

0.36

2859

22843

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

432

2.76

23.78

1.4

e6/l

41200.6

45630.0

0.07

249

(3006504) Eosinophils/100 leukocytes in Blood

4303

36383

1.24

23.09

5.3

5.7

2.7

2.9

10.24

3958

33355

(3022096) Basophils/100 leukocytes in Blood

4184

35301

1.24

22.80

5.3

5.8

0.7

2.92

3849

32374

(3013512) EKG study

3020

24577

1.26

22.76

3.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

325

1737

1.82

22.37

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2235

25871

0.78

22.26

3.6

3.8

mg/mmol

5.7

7.1

1.21

1163

14591

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

949

6555

1.43

22.25

3.4

2.8

mmol/l

1.2

0.61

852

5463

(3023199) Leukocytes [#/volume] in Pleural fluid

131

492

2.58

22.23

1.4

e6/l

2644.6

2923.4

0.09

358

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

201

913

2.14

22.11

1.2

u/l

56.0

58.2

0.30

134

608

(3018010) Neutrophils/100 leukocytes in Blood

4355

36994

1.23

21.97

5.2

5.7

57.5

56.6

5.20

4008

34072

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

199

918

2.10

21.05

1.6

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

221

1067

2.01

20.68

1.3

u/l

37.1

36.6

0.07

205

815

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8807

81159

1.35

20.28

16.1

12.1

mg/l

21.8

20.2

4.54

7171

62484

(3012516) Albumin [Mass/volume] in Urine

2129

24572

0.79

20.25

2.9

3.1

mg/l

516.4

405.3

0.39

1108

13649

(3044889) 12 lead EKG panel

6509

57919

1.23

19.87

3.8

3.7

—

(3009508) Creatinine [Moles/volume] in Urine

2223

25433

0.79

19.42

2.9

3.0

mmol/l

6.2

6.3

0.32

1780

21177

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

371

2146

1.69

19.41

1.5

1.3

pmol/l

194.4

76.9

4.01

360

2099

(3021589) Normoblasts [#/volume] in Blood

4101

34919

1.22

19.32

10.1

8.3

e9/l

0.0

0.93

3265

28502

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

321

1811

1.73

18.42

1.6

2.0

95.3

95.6

0.07

301

1630

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

272

1466

1.80

18.28

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

272

1466

1.80

18.28

1.2

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

207

1024

1.96

18.14

1.3

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

306

1719

1.73

17.84

1.8

2.2

196.3

181.5

2.05

293

1599

(36304419) Bacteria [Presence] in Urine

2509

20454

1.24

17.68

2.8

2.9

—

(3045788) Cell count panel - Pleural fluid

104

392

2.56

17.62

1.6

1.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

287

1589

1.76

17.62

1.9

2.4

g/l

3.6

0.04

278

1488

(3007853) Bacteria identified in Skin by Aerobe culture

1162

8607

1.34

17.60

1.7

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

787

5478

1.41

17.57

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

5.27

17.32

1.1

1.4

ug/l

637.8

37.3

0.55

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1501

11562

1.29

17.06

2.5

2.6

e6/l

4.1

4.9

1.46

750

5944

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

184

3.30

16.90

2.3

2.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

255

2.92

16.72

1.2

1.3

u/l

10.4

10.6

0.04

216

(3014111) Lactate [Moles/volume] in Serum or Plasma

789

5544

1.40

16.66

5.7

5.5

mmol/l

1.3

1.70

765

5342

(3030467) Casts [#/volume] in Urine by Automated count

2545

20940

1.22

16.16

2.9

e6/l

0.4

0.06

1838

15470

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4485

38928

1.19

16.15

2.2

2.3

nmol/l

81.3

2469.7

0.50

3957

34320

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

491

3184

1.51

15.87

7.3

7.4

mmol/l

24.7

0.11

466

2895

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

465

2984

1.52

15.80

2.1

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

433

2743

1.54

15.62

1.9

1.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

9160

85379

1.35

15.60

17.5

14.1

mmol/l

139.7

139.8

7.24

8938

82877

(3003396) Base excess in Arterial blood by calculation

995

7328

1.34

15.59

5.8

5.9

mmol/l

1.1

1.4

2.17

832

5743

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8244

82120

0.80

15.36

4.6

4.8

mmol/l

5.8

5.9

3.40

7344

74589

(3002582) Erythrocytes [#/volume] in Urine

2707

22518

1.21

15.22

2.9

3.0

e6/l

109.3

74.5

0.42

1962

16732

(3000991) Gas panel - Venous blood

729

5147

1.39

14.94

6.8

6.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

121

530

2.21

14.74

1.3

1.2

u/l

19.6

21.0

0.10

103

449

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

372

2311

1.57

14.66

1.9

1.8

ug/l

1.1

2.2

3.13

334

1964

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

122

541

2.18

14.43

1.3

1.2

u/l

63.8

79.2

1.71

111

474

(3027801) Oxygen [Partial pressure] in Arterial blood

987

7354

1.32

14.23

5.9

kpa

13.6

11.9

12.14

950

6964

(3004809) Band form neutrophils/100 leukocytes in Blood

171

864

1.92

14.18

3.0

2.8

1.8

1.0

1.77

136

658

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

987

7358

1.32

14.17

5.9

kpa

5.1

0.96

950

6972

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

128

584

2.12

14.09

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

185

963

1.86

14.01

1.4

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

296

1761

1.63

13.99

2.5

3.1

u/ml

0.4

0.55

165

1056

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1357

10563

1.27

13.98

1.9

1.8

29.4

0.12

1313

10196

(3023103) Potassium [Moles/volume] in Serum or Plasma

9165

85599

1.33

13.92

17.7

14.2

mmol/l

3.9

6.92

8932

82917

(3019150) Specific gravity of Urine by Refractometry

1659

18971

0.81

13.48

4.6

4.7

kg/l

1.0

0.11

264

2953

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

353

2.41

13.19

1.4

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

555

3821

1.42

13.18

7.4

7.5

94.6

93.4

6.06

555

3810

(3051651) Icteric interference index of Serum or Plasma

330

2.46

13.17

2.4

3.9

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

316

1949

1.58

12.89

2.3

2.9

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

552

3814

1.41

12.84

7.4

0.7

2.00

552

3792

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

555

3848

1.41

12.66

7.3

1.3

1.4

3.81

555

3822

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

183

985

1.80

12.49

3.1

1.9

u/ml

492.3

66.8

0.94

161

882

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8059

80166

0.82

12.41

5.5

5.4

mu/l

1.9

2.1

2.00

7254

73462

(3035637) Corticotropin [Mass/volume] in Plasma

143

714

1.94

12.35

1.5

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

285

2.51

12.13

1.5

u/l

11.8

13.0

1.03

274

(3018095) Leukocytes [#/volume] in Urine

3219

27642

1.17

12.00

3.4

3.5

e6/l

117.4

123.0

0.14

2139

18512

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

381

2.28

11.98

5.7

1.2

u/ml

60.8

297.6

2.60

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

121

577

2.03

11.92

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

108

495

2.11

11.83

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

115

3.43

11.81

1.7

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

217

2.71

11.73

2.2

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

217

2.71

11.73

2.2

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

224

2.67

11.58

2.2

1.3

—

(44790047)

119

574

2.00

11.38

1.4

—

(44790048)

119

574

2.00

11.38

1.4

—

(44806118)

119

574

2.00

11.38

1.4

—

(44790049)

119

574

2.00

11.38

1.4

—

(3036489) Thrombin time

375

2472

1.47

11.26

1.5

1.8

21.3

21.4

0.11

339

2108

(3013115) Eosinophils [#/volume] in Blood

4616

40910

1.16

11.11

5.2

5.7

e9/l

0.2

26.93

3905

35658

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1446

16481

0.82

11.09

1.2

1.3

u/ml

10.8

13.9

1.05

518

6258

(3019198) Lymphocytes [#/volume] in Blood

4558

40375

1.15

11.01

5.2

5.6

e9/l

1.7

1.9

14.46

3896

35306

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1519

17196

0.82

10.85

1.3

iu/ml

35.3

37.9

0.27

466

5581

(3014576) Chloride [Moles/volume] in Serum or Plasma

1054

8195

1.26

10.84

6.1

5.5

mmol/l

104.0

103.9

0.25

1029

8003

(21494814) CD8 cells/100 lymphocytes in Specimen

147

3.01

10.77

1.8

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

489

3413

1.40

10.77

1.4

1.3

iu/l

45.3

36.6

5.46

406

2999

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

297

2.37

10.69

2.1

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

297

2.37

10.69

2.1

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

297

2.37

10.69

2.1

1.3

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

4.54

10.52

1.0

1.1

nmol/l

0.3

0.4

0.36

(3002173) Hemoglobin [Mass/volume] in Arterial blood

789

5942

1.30

10.47

6.6

6.5

g/l

117.4

119.9

3.45

772

5684

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

300

2.35

10.46

2.1

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

956

1.73

10.33

3.5

4.8

iu/ml

673.2

770.8

0.08

127

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

10.26

1.0

0.0

—

(3045142) Bone marrow Pathology biopsy report

102

485

2.03

10.20

1.3

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1595

13042

1.21

10.17

2.4

2.5

e6/l

1.2

1.4

0.86

842

7375

(3016502) Oxygen saturation in Arterial blood

845

6460

1.28

9.97

6.2

96.2

95.5

2.98

825

6184

(3001604) Monocytes [#/volume] in Blood

4430

39333

1.15

9.97

5.1

5.5

e9/l

0.6

0.82

3700

33727

(3024891) Influenza virus A+B Ag [Presence] in Specimen

271

1720

1.53

9.83

1.1

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

7237

66526

1.16

9.80

20.4

14.5

13.8

13.7

9.69

7123

64886

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

303

2.29

9.80

1.7

1.9

14.0

14.6

0.11

149

(3006315) Basophils [#/volume] in Blood

4448

39534

1.15

9.80

5.1

5.5

e9/l

0.0

9.38

3704

33876

(3026782) Osmolality of Urine

1763

14599

1.19

9.77

2.5

2.7

mosm/kgh2o

495.3

504.1

1.01

1463

12132

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

286

2.33

9.73

1.6

2.0

—

(1175426) CD3 cells/100 lymphocytes in Blood

312

2.26

9.59

1.7

1.9

71.9

74.1

0.59

297

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

427

2.06

9.46

1.1

u/l

15.4

19.5

0.69

311

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

107

534

1.93

9.37

1.9

1.3

—

(3014891) Appearance of Pleural fluid

3.74

9.21

1.4

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

426

2.04

9.16

1.1

u/l

75.5

76.5

0.05

322

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

115

3.10

9.13

4.1

1.2

ng/l

59.1

73.1

0.21

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

107

540

1.91

9.08

1.7

1.5

u/l

6.4

6.2

0.05

246

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7030

70251

0.87

8.84

4.6

4.5

pmol/l

14.9

2.08

6299

63901

(3035880) pH of Pleural fluid

221

2.44

8.83

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1041

8286

1.23

8.63

2.2

2.1

umol/l

7.0

6.3

0.55

877

6923

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

132

725

1.76

8.57

1.3

1.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

317

2.13

8.05

2.1

1.9

38.9

46.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9243

87081

1.25

8.03

13.2

9.2

u/l

24.1

23.4

2.09

8955

83197

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

111

591

1.81

8.03

1.8

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

881

6945

1.24

7.99

2.1

2.2

u/l

36.5

36.0

0.05

739

5812

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

134

758

1.71

7.88

1.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

127

708

1.73

7.87

2.1

2.3

u/ml

488.3

1134.2

—

(40765096) Chromosome analysis panel by Banding

3.37

7.68

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

4.18

7.65

1.5

1.1

ug/l

1.3

3.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.14

7.61

1.1

—

(3011412) CD3 cells [#/volume] in Blood

424

1.93

7.54

2.4

2.1

e9/l

0.9

1.2

2.52

227

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

1029

1.59

7.47

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

327

2278

1.39

7.39

3.0

3.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

502

1.84

7.39

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

502

1.84

7.39

1.9

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

502

1.84

7.39

1.9

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

136

791

1.66

7.24

1.7

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

6106

55979

1.12

7.05

4.9

e6/l

5091.7

2591.2

1.10

680

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1832

19741

0.87

6.85

1.3

u/ml

1.9

1.4

0.50

401

5253

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2157

18609

1.14

6.82

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

137

812

1.63

6.81

1.2

u/l

21.2

18.7

0.92

121

644

(40768443) Skin Pathology biopsy report

478

3573

1.30

6.78

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

793

6298

1.23

6.72

3.4

2.3

ml/min/173m2

65.9

64.4

0.59

339

2475

(3037522) Nuclear Ab [Titer] in Serum

1117

12480

0.84

6.64

1.3

1.4

titre

481.7

611.0

1.90

264

2919

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1784

19216

0.87

6.61

1.6

1.7

pmol/l

60742793.6

35055831.0

0.72

1401

15621

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

147

894

1.59

6.59

1.3

—

(3022475) Manganese [Moles/volume] in Blood

4.03

6.58

1.1

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1082

8872

1.19

6.58

4.4

4.3

mmol/l

1.0

0.29

989

8039

(3027945) Reticulocytes/100 erythrocytes in Blood

933

7549

1.21

6.56

2.2

1.8

0.40

821

6492

(21494755) Public health laboratory ask at order entry panel

463

5656

0.78

6.50

1.3

—

(4034850)

224

3049

0.70

6.49

12.1

9.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

447

1.83

6.48

1.3

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

314

4038

0.74

6.42

1.3

u/ml

2.5

0.7

0.66

373

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

113

649

1.68

6.37

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

108

1692

0.61

6.20

2.4

2.3

ug/min

122.9

63.8

0.69

910

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

430

3213

1.30

6.15

7.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

640

5032

1.24

5.99

5.8

6.1

mmol/l

9.2

9.8

1.58

611

4749

(3008757) Leukocyte morphology finding [Identifier] in Blood

109

632

1.66

5.96

3.2

2.9

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

171

2.31

5.85

1.1

1.9

u/ml

703.4

61481.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

275

3554

0.74

5.84

1.4

1.5

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

125

2.54

5.79

1.4

1.3

59.4

57.5

0.11

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

297

2127

1.35

5.75

1.2

—

(40761535) Cells panel - Urine sediment

614

7157

0.81

5.73

3.7

3.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

537

1.71

5.72

2.3

2.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

180

2486

0.69

5.71

1.4

1.6

iu/ml

8.3

8.0

0.01

538

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1160

9687

1.17

5.67

2.2

2.4

20.7

21.6

1.42

1002

8067

(3018834) Bilirubin.total [Presence] in Urine by Test strip

6.01

5.65

3.3

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3112

32123

0.90

5.55

4.3

4.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1428

0.61

5.32

1.3

1.7

nmol/l

0.8

0.08

1171

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

185

2.19

5.31

1.9

2.5

42.2

46.9

0.84

(3008898) HLA-B27 [Presence]

207

2737

0.72

5.13

1.0

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.94

5.09

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

128

804

1.54

5.09

2.6

3.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

812

1.53

5.08

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

335

1.84

5.05

1.2

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

100

594

1.62

5.04

3.3

2.6

59.3

59.9

0.07

390

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.70

4.93

1.9

3.7

mg/l

0.6

1.9

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

107

2.52

4.87

1.4

1.3

3.4

2.3

0.27

(3029937) Albumin [Presence] in Urine by Test strip

2158

22584

0.90

4.84

4.5

4.6

estimate

0.0

1.90

749

7207

(3002331) Protein [Mass/volume] in Peritoneal fluid

102

2.55

4.81

1.3

1.6

g/l

38.1

22.4

6.06

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1237

10513

1.15

4.77

2.1

2.3

g/l

2.4

1.83

1127

9556

(3021879) Hepatitis B virus core Ab [Presence] in Serum

513

4051

1.23

4.67

1.2

1.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2073

18242

1.12

4.55

1.6

1.7

mg/l

1.2

1.1

1.65

1603

13889

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.21

4.55

1.4

1.3

20.7

11.6

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

160

2.17

4.50

1.8

2.3

e6/l

6143.5

1439.0

0.43

110

(3009542) Hematocrit [Volume Fraction] of Blood

7705

72193

1.11

4.46

18.1

13.6

38.3

38.9

5.75

5463

49388

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.43

4.45

1.3

1.1

—

(3044007) Cell count panel - Peritoneal fluid

130

2.29

4.45

2.0

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.68

4.35

2.1

2.0

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

338

1.77

4.34

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

338

1.77

4.34

1.4

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

165

1128

1.41

4.34

2.1

2.0

mg/l

26.2

25.4

0.06

291

(3022217) INR in Platelet poor plasma by Coagulation assay

1193

10184

1.14

4.32

24.6

24.4

inr

1.3

0.10

153

1427

(3048689) Calprotectin [Mass/mass] in Stool

976

10656

0.87

4.28

1.8

2.0

ug/g

142.0

118.0

0.43

726

8100

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2700

24157

1.10

4.26

2.8

ng/l

1297.0

1227.6

0.39

2286

20379

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

292

1.81

4.21

1.3

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

300

1.80

4.17

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1036

0.60

4.15

1.1

iu/ml

78.7

12051.5

0.55

198

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

502

4015

1.21

4.07

1.4

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

3.47

3.93

1.3

1.2

g/l

15.8

14.9

0.16

(3022948) Iron [Moles/volume] in Serum or Plasma

1340

11594

1.13

3.93

2.2

2.3

umol/l

12.2

12.8

2.67

1227

10513

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

807

8867

0.86

3.88

1.7

1.6

—

(3000850) Epithelial cells [#/volume] in Urine

1801

15866

1.11

3.83

2.5

e6/l

8.2

7.4

0.84

1547

13667

(4010399)

584

6565

0.85

3.76

1.4

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

243

2985

0.78

3.71

1.5

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

188

1.95

3.65

1.1

1.4

—

(3017181) Myelocytes/100 leukocytes in Blood

743

6210

1.16

3.64

3.6

3.8

1.5

0.7

5.96

270

1190

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.43

3.63

1.0

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

836

7051

1.15

3.62

3.0

3.1

ng/l

82.8

81.8

0.13

707

5879

(3008295) Osmolality of Serum or Plasma

116

773

1.45

3.58

1.4

mosm/kgh2o

275.7

274.0

0.34

579

(3033799) Differential panel - Peritoneal fluid

126

2.14

3.47

2.0

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

608

6762

0.85

3.45

1.2

1.3

—

(40768441) Liver Pathology biopsy report

385

1.63

3.44

1.2

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

456

0.46

3.40

1.2

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

310

3660

0.81

3.39

1.4

1.5

—

(3003338) MCHC [Mass/volume]

6890

67811

0.92

3.37

22.0

16.2

g/l

329.8

330.4

7.90

6838

67301

(1761868) Lipid panel - Serum or Plasma

2673

27274

0.92

3.35

2.9

3.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1277

0.68

3.32

1.1

u/ml

0.9

0.00

449

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

212

2603

0.78

3.27

1.3

u/ml

3.3

4.6

0.32

297

(3042631) Mycobacterium sp identified in Specimen

119

814

1.41

3.23

2.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

712

5994

1.15

3.20

2.5

1.5

g/l

65.5

66.8

4.38

639

5257

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

216

2636

0.78

3.18

1.3

u/ml

9.1

7.3

0.17

477

(44786800) Granulocytes/100 leukocytes in Body fluid

2.98

3.13

1.2

1.3

29.1

24.3

—

(3026008) Bacteria identified in Urine by Culture

3275

29873

1.08

3.13

3.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

343

1.63

3.12

2.2

2.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

4.55

3.12

1.0

u/l

352.0

194.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

472

1.53

3.11

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

132

2.04

3.11

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

450

1.54

3.08

1.8

1.7

—

(40761536) Microorganisms panel - Urine sediment

769

6531

1.14

3.05

4.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

702

5926

1.15

3.05

3.0

2.9

pmol/l

4.4

0.34

625

5139

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

416

4719

0.84

3.04

1.8

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5457

50740

1.07

3.03

3.0

2.9

u/l

46.7

40.5

4.38

4953

46556

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

1.94

3.00

1.1

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

218

2634

0.79

2.98

1.3

1.7

g/l

0.2

0.05

207

2485

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.56

2.97

1.4

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

373

2999

1.20

2.96

3.7

3.6

mmol/l

24.6

24.5

0.15

329

2652

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

478

1.51

2.96

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

243

2890

0.80

2.90

1.5

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.26

2.87

1.1

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

482

5372

0.85

2.86

1.3

u/ml

170.4

181.6

0.10

431

4949

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

181

2223

0.78

2.85

1.6

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

148

1073

1.33

2.84

1.8

1.7

mmol/l

1.7

0.31

143

1051

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

175

2156

0.78

2.82

1.3

u/ml

1.2

6.5

2.09

162

(3017143) Hepatitis C virus Ab [Presence] in Serum

762

6506

1.14

2.81

1.4

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

224

2677

0.80

2.80

1.3

1.7

g/l

1.2

0.71

214

2526

(3000494) Fungus identified in Specimen by Culture

1068

9306

1.11

2.80

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

195

0.34

2.79

1.4

1.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

243

2875

0.81

2.78

1.2

1.3

u/ml

33.4

45.9

0.29

186

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

325

2601

1.21

2.74

3.6

3.5

mmol/l

25.2

0.03

298

2348

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

146

1.91

2.72

2.0

1.9

e6/l

13556.2

25836.6

0.31

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

101

696

1.40

2.69

5.3

6.2

mg/l

11.9

12.4

0.61

619

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

366

4147

0.84

2.68

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

107

1396

0.73

2.63

1.3

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1954

20007

0.92

2.59

2.4

2.1

umol/l

5740.8

4963.0

0.33

1637

16840

(3036481) Cortisol [Moles/volume] in Serum or Plasma

859

7430

1.12

2.58

2.4

1.8

nmol/l

389.0

370.4

1.91

792

6706

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

472

3927

1.16

2.55

3.2

mmol/l

2.1

0.01

369

2993

(3012501) Base excess in Blood by calculation

192

1466

1.26

2.54

3.2

3.4

mmol/l

2.7

0.06

149

1035

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

219

0.39

2.54

2.3

2.9

mg/l

6.7

7.3

—

173

(3014133) Dog dander IgE Ab [Units/volume] in Serum

870

0.67

2.51

1.0

u/ml

5.6

2.7

0.58

306

(3022313) Gas panel - Capillary blood

360

2935

1.18

2.50

3.4

3.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

192

2298

0.80

2.48

1.4

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

657

5610

1.13

2.46

2.3

2.2

e9/l

69.1

71.3

0.81

483

4231

(40761511) CBC panel - Blood by Automated count

8902

84536

1.10

2.45

15.1

11.8

—

(3026470) Cobalt [Mass/volume] in Blood

570

0.61

2.40

1.9

2.0

ug/l

2.5

4.3

2.22

507

(3003888) Timothy IgE Ab [Units/volume] in Serum

1140

0.72

2.37

1.0

1.1

u/ml

5.3

2.7

0.45

516

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.33

2.37

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

983

0.70

2.37

1.0

1.1

u/ml

0.5

1.1

0.80

212

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1015

0.71

2.35

1.2

1.3

mmol/l

7.0

7.5

0.76

729

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1102

0.72

2.32

1.0

1.1

u/ml

1.3

0.8

0.35

414

(3002032) Base excess in Venous blood by calculation

736

6356

1.12

2.30

3.3

3.4

mmol/l

2.1

2.2

0.46

610

5273

(40758292) HTLV I+II Ab panel - Serum

2.71

2.29

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

670

5756

1.13

2.29

3.6

3.7

1.0

0.5

3.24

188

893

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2353

23823

0.93

2.29

1.6

mmol/l

1.3

1.72

1940

19850

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.20

2.28

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

227

2641

0.82

2.27

1.6

titre

146.7

283.2

1.97

156

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

301

0.48

2.23

9.0

10.3

nmol/l

796.6

813.2

0.04

287

(3024869) Neuronal Ab [Presence] in Serum

109

1.94

2.21

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

614

0.64

2.18

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.34

2.17

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1262

11235

1.09

2.17

4.6

4.8

34.2

33.5

1.18

767

7412

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

183

1420

1.24

2.16

2.8

3.3

58.7

57.5

0.54

183

1420

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

647

0.65

2.16

1.0

ng/l

46.5

48.3

0.10

445

(44806420)

257

0.45

2.14

2.5

2.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

611

0.64

2.14

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

200

2339

0.82

2.13

1.7

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

712

0.67

2.10

1.0

u/ml

1.0

0.3

—

147

(3009343) pH of Capillary blood

481

4073

1.14

2.09

3.2

7.4

2.11

521

(3003181) Sodium [Moles/volume] in Urine

207

1634

1.22

2.09

1.4

mmol/l

65.4

61.7

0.52

160

1304

(3027923) C peptide [Moles/volume] in Serum or Plasma

404

0.57

2.07

1.4

1.5

nmol/l

1.2

1.3

0.17

325

(3022145) Colonoscopy Study observation

1007

8895

1.10

2.07

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2798

25695

1.06

2.06

2.5

2.2

u/l

59.7

58.3

0.41

2524

23249

(3023430) Cat dander IgE Ab [Units/volume] in Serum

810

0.70

2.05

1.0

1.1

u/ml

4.2

2.7

0.25

296

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

278

0.48

2.05

1.9

1.7

ug/l

10.0

8.7

0.70

278

(3022689) Creatine [Moles/volume] in Urine

265

0.47

2.05

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

732

6367

1.11

2.04

3.3

3.4

kpa

5.8

5.9

0.59

708

6177

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

637

0.66

2.02

1.0

ng/l

1133.6

348.2

0.47

445

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

314

0.52

2.01

1.1

miu/ml

1666.6

1571.7

0.13

314

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

177

1382

1.23

2.00

1.4

1.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

693

6021

1.11

1.98

3.8

3.9

0.3

0.1

4.04

252

1115

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

156

1.73

1.98

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

425

1.43

1.98

1.0

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2628

26397

0.94

1.97

1.9

2.0

u/l

150.2

170.0

1.09

2444

24449

(3025468) Yersinia sp identified in Specimen by Organism specific culture

136

1032

1.27

1.97

1.6

1.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

485

4129

1.13

1.96

3.2

3.3

kpa

5.2

0.03

454

3763

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

193

0.45

1.95

1.3

1.7

—

84.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

643

0.67

1.95

1.0

ng/l

741.9

716.1

0.13

429

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

313

3487

0.86

1.95

1.7

1.6

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

688

0.68

1.94

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

188

1483

1.22

1.94

2.1

2.7

mg/l

1.4

1.6

1.62

166

1326

(3035350) Ketones [Presence] in Urine by Test strip

4213

41734

0.95

1.94

3.9

4.1

estimate

0.0

0.23

761

7113

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

1044

1.26

1.93

1.6

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

468

1.40

1.92

2.0

1.5

—

(3025130) Human papilloma virus identified in Specimen

174

1365

1.23

1.90

1.6

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

841

0.72

1.89

1.9

1.5

37.0

32.8

0.36

479

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

344

0.56

1.89

1.2

—

(3004775) Volume in Urine collected for unspecified duration

569

0.66

1.88

2.1

2.3

631.8

631.4

0.00

409

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

430

1.41

1.87

1.0

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

100

1241

0.77

1.83

1.4

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

758

0.71

1.83

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

678

0.69

1.82

1.1

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.19

1.80

1.0

2.3

—

(1002224) Polysomnography panel

252

2835

0.85

1.80

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

177

1401

1.22

1.79

2.4

16.2

0.03

693

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

134

1031

1.25

1.77

1.6

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6147

57858

1.05

1.76

4.6

4.7

—

(3007916) DNA double strand Ab [Titer] in Serum

146

0.39

1.76

1.2

1.3

—

214.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

463

3964

1.13

1.75

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

136

1050

1.25

1.74

1.6

1.3

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

637

0.69

1.73

1.1

1.2

titre

32.0

188.3

—

120

(3010421) pH of Blood

215

1742

1.19

1.71

3.1

3.3

7.4

0.13

188

1426

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.22

1.71

1.1

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

134

1036

1.25

1.70

1.6

1.3

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

635

0.69

1.70

1.1

1.2

—

138.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

271

0.53

1.70

1.3

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

472

1.37

1.69

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

415

1.39

1.69

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

614

1.32

1.67

2.1

2.5

—

(3000012) Reticulocyte production index

392

1.40

1.66

1.4

—

(3049717) Cytology report of Urine Cyto stain

224

1829

1.18

1.65

2.3

1.8

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.04

1.65

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

742

1.28

1.64

1.9

2.2

u/field

2.7

2.9

0.11

263

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

685

1.29

1.61

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

101

1.81

1.61

1.1

1.2

mmol/l

1.9

1.8

0.02

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.84

1.61

7.8

1.3

u/l

37.8

43.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

131

1019

1.24

1.60

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

188

2142

0.84

1.60

1.2

1.3

u/ml

31.9

48.5

0.80

238

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.48

1.57

1.1

—

(3019060) Gas panel - Arterial blood

510

4423

1.11

1.57

3.9

4.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

488

0.67

1.57

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.90

1.57

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.20

1.56

1.3

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

426

4567

0.89

1.55

1.0

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

566

0.69

1.55

1.4

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

555

1.32

1.54

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

104

1251

0.80

1.53

1.3

1.5

g/l

0.5

0.7

1.71

940

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

427

0.65

1.52

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.80

1.52

3.2

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.88

1.52

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.88

1.52

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

184

1491

1.19

1.50

1.5

1.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

806

0.75

1.50

1.3

1.2

u/ml

8.1

46.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

118

915

1.24

1.50

1.3

u/ml

121.4

122.4

0.01

208

(3049242) von Willebrand panel - Platelet poor plasma

2.59

1.50

3.4

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.59

1.50

1.0

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

137

1081

1.22

1.48

1.6

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2055

20627

0.95

1.48

3.8

4.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

380

4087

0.89

1.48

1.1

titre

492.2

185.5

1.07

(3009466) Valproate [Moles/volume] in Serum or Plasma

1062

0.78

1.46

4.0

4.9

umol/l

365.3

374.1

0.25

912

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.20

1.46

3.4

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

864

7717

1.08

1.44

1.4

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

269

2951

0.87

1.44

1.6

1.7

—

(21494434) Karyotype in Bone marrow

478

1.33

1.44

1.2

1.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1715

15700

1.06

1.40

3.4

3.7

ng/l

136.1

313.3

5.28

1338

11835

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.40

1.37

1.0

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

111

1306

0.81

1.37

1.2

1.3

u/ml

78.1

58.8

—

103

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

804

0.76

1.37

1.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.62

1.36

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

158

0.49

1.35

1.1

1.3

nmol/l

26.3

27.8

—

130

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1845

16946

1.06

1.34

3.9

4.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

387

4128

0.90

1.33

1.8

—

(3044927) Protein electrophoresis panel - Urine

853

0.78

1.32

1.1

1.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

161

1.55

1.31

1.5

2.0

12.0

8.4

0.96

151

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.40

1.30

1.1

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.77

1.29

1.2

1.7

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

223

0.56

1.29

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

223

0.56

1.29

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

223

0.56

1.29

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

223

0.56

1.29

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

655

0.75

1.29

1.0

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

653

6779

0.92

1.29

2.2

2.3

ug/l

5.1

5.8

0.69

522

5715

(3034891) Synovial lining cells/100 cells in Synovial fluid

466

0.70

1.28

1.6

1.5

3.1

4.3

0.29

(3003740) Influenza virus B Ag [Presence] in Specimen

113

891

1.22

1.28

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.78

1.24

1.0

1.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3562

35135

0.96

1.23

2.6

2.8

ug/l

121.1

96.0

6.35

3198

32200

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.20

1.22

2.4

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

130

1045

1.20

1.22

1.1

—

(3009261) Glucose [Presence] in Urine by Test strip

4311

42346

0.96

1.20

4.0

4.1

estimate

0.0

2.28

770

7195

(3013707) Erythrocyte sedimentation rate by Westergren method

6584

64132

0.96

1.20

4.1

4.4

mm/h

14.1

12.8

10.20

5971

59120

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

101

793

1.23

1.20

1.9

1.6

32.5

31.9

0.72

101

784

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

104

1.66

1.20

1.1

1.4

nmol/l

1300007.6

359265.8

0.47

(3025159) Blasts/100 leukocytes in Blood

648

5772

1.08

1.20

3.7

3.9

0.5

0.2

0.37

212

987

(3002523) Influenza virus A Ag [Presence] in Specimen

112

891

1.21

1.18

1.0

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

151

1698

0.85

1.18

1.3

1.2

mmol/l

3.5

3.7

1.47

142

1593

(3016879) Cocaine [Presence] in Urine

107

1240

0.83

1.17

2.3

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

752

0.78

1.17

1.0

1.1

—

72.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

378

0.69

1.16

1.0

1.1

u/l

1.2

1.1

0.36

179

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

621

0.76

1.16

1.8

1.7

—

(3006270) Folate [Moles/volume] in Blood

763

1.22

1.15

1.2

nmol/l

327.9

361.7

0.87

639

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

587

0.75

1.14

1.3

mmol/l

12.3

11.6

0.16

129

(3021601) Nitrite [Presence] in Urine by Test strip

4273

41946

0.96

1.14

5.4

5.5

estimate

0.0

1.84

753

7147

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

389

1.31

1.11

1.6

1.9

—

(3011288) Drugs identified in Urine by Screen method

916

0.81

1.11

1.8

2.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

306

1.35

1.11

3.0

2.2

e6/l

759.3

1130.7

0.55

156

(3001729) Color of Synovial fluid

1.78

1.10

2.5

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

315

1.34

1.09

3.1

2.1

e9/l

0.2

0.16

275

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

152

1695

0.86

1.09

1.5

1.4

e6/l

730.2

1471.7

0.97

114

1402

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

332

1.33

1.08

3.0

2.1

e6/l

498.6

556.2

0.19

280

(3016650) Hepatitis A virus Ab [Presence] in Serum

126

1024

1.18

1.08

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

152

1693

0.86

1.07

1.5

1.4

e6/l

26.4

32.7

0.18

104

1327

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

762

0.79

1.06

1.3

1.2

u/ml

2.2

10.4

—

(3028707) Methadone [Presence] in Urine by Screen method

644

0.77

1.06

3.3

1.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

814

0.80

1.05

1.2

1.4

g/l

0.4

0.15

577

(3027135) IgG subclass 1 [Mass/volume] in Serum

814

0.80

1.05

1.2

1.4

g/l

6.3

6.7

0.49

575

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

102

1171

0.83

1.04

1.7

1.6

58.1

55.1

0.36

708

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

670

6879

0.93

1.04

1.6

1.4

0.06

560

5967

(3028192) IgG subclass 2 [Mass/volume] in Serum

813

0.80

1.04

1.2

1.4

g/l

2.6

2.9

0.95

573

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

143

0.54

1.03

1.3

1.2

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

140

1.51

1.03

1.5

69.9

71.4

0.20

135

(44813793)

673

0.78

1.03

1.2

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

480

4257

1.09

1.02

6.0

6.3

mmol/l

25.1

24.9

0.54

453

3924

(3007164) IgA [Mass/volume] in Serum or Plasma

1606

16057

0.95

1.02

1.4

1.3

g/l

2.2

2.3

1.42

836

9029

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1126

0.83

1.02

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1052

0.83

1.01

2.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

103

0.47

1.01

1.0

1.1

—

(3016750) Collection duration of Urine

410

0.73

1.00

2.0

2.2

min

482.6

503.3

0.83

322

(3022621) pH of Urine by Test strip

588

6055

0.93

1.00

3.6

3.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

252

0.65

1.00

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

387

4051

0.91

0.98

1.3

1.4

—

(3000285) Sodium [Moles/volume] in Blood

130

0.52

0.98

1.4

1.3

—

(3021901) Oxygen saturation in Capillary blood

137

1133

1.16

0.98

2.5

2.7

—

(4027681)

385

0.72

0.97

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

203

0.61

0.96

1.7

1.5

—

(4024509)

130

1073

1.17

0.95

1.8

1.7

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

199

1.40

0.95

2.5

2.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1044

0.84

0.95

1.2

u/l

28.4

25.8

0.17

901

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

174

1897

0.88

0.94

1.3

miu/ml

226.8

220.6

0.07

911

(3032868) Hemoglobin electrophoresis panel in Blood

1.76

0.94

1.6

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

343

3012

1.10

0.93

1.6

g/l

1.6

0.02

282

2551

(3024354) Oxygen [Partial pressure] in Venous blood

601

5402

1.07

0.93

2.8

2.9

kpa

4.6

4.4

0.62

580

5238

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

281

0.68

0.92

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

275

1.33

0.91

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

893

0.83

0.91

1.4

—

(3037121) Protein [Mass/volume] in Urine

282

2457

1.11

0.91

2.8

2.4

g/l

0.2

0.3

6.91

641

(4062490)

808

0.82

0.90

1.2

1.5

—

(3017732) Neutrophils [#/volume] in Blood

635

5727

1.07

0.90

3.0

2.7

e9/l

3.7

3.9

1.46

473

4225

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

268

0.68

0.90

1.9

1.6

—

(3017704) Immunofixation for Urine

367

0.73

0.88

1.5

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

370

1.27

0.88

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

805

0.82

0.87

1.3

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

138

1.46

0.87

1.6

mu/l

359.0

524.0

1.30

133

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

620

6332

0.94

0.86

1.2

iu/ml

151.4

148.8

0.05

221

2509

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

271

2364

1.10

0.86

1.8

2.1

ug/l

382.9

589.8

1.00

238

2189

(3019977) pH of Arterial blood

347

1.27

0.84

2.5

2.4

7.4

0.16

119

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.57

0.84

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

215

1856

1.12

0.84

3.4

nmol/l

0.8

0.15

167

1477

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.75

0.82

1.7

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

205

0.66

0.81

1.4

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

328

0.73

0.81

1.3

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.86

0.81

3.7

3.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

899

0.84

0.79

1.1

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.79

0.0

2.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

753

1.18

0.79

1.1

94.6

94.5

0.02

706

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

145

0.60

0.78

1.4

1.6

mmol/l

1.2

—

139

(3051593) INR in Capillary blood by Coagulation assay

377

1.25

0.78

8.8

10.4

—

(3000764) Benzodiazepines [Presence] in Urine

123

1350

0.87

0.78

2.1

1.6

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.80

0.78

8.8

1.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

142

1542

0.88

0.77

1.4

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.55

0.76

1.1

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

310

1.27

0.76

2.1

2.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

257

0.71

0.75

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

111

1.47

0.74

1.5

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.09

0.74

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

116

1272

0.87

0.74

1.6

—

(3037756) Immunofixation for Serum or Plasma

163

1399

1.12

0.73

1.4

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

177

0.65

0.73

1.0

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

419

0.78

0.73

1.0

u/ml

0.4

1.1

0.53

124

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

335

2981

1.08

0.73

4.0

4.2

1.6

0.65

323

2787

(3009871) Measles virus Ab [Titer] in Serum

244

0.71

0.72

1.4

1.7

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

331

2945

1.08

0.72

4.0

4.2

0.9

0.05

319

2752

(3028300) Cannabinoids [Presence] in Urine

125

1361

0.88

0.72

2.1

1.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

154

1320

1.12

0.71

2.4

2.7

kpa

8.1

0.03

143

1222

(3000570) Elastase.pancreatic [Mass/mass] in Stool

245

2568

0.91

0.71

1.3

1.4

ug/g

278.2

293.0

0.55

135

1443

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

181

1925

0.90

0.70

1.3

mg/l

547.9

510.7

0.33

173

1816

(3000492) Spirometry study

785

7192

1.05

0.70

1.4

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

1.92

0.70

1.2

3.9

umol/l

49.6

259.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.92

0.70

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

152

0.63

0.70

1.3

1.7

mmol/l

1.2

—

147

(3036603) Volume of Urine

488

1.20

0.70

1.4

1.5

1634.9

1891.9

0.75

117

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1127

11244

0.96

0.70

7.1

6.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3759

36734

0.97

0.69

2.0

pmol/l

99.4

99.8

0.15

1641

16720

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

445

1.21

0.69

1.6

2.0

u/field

0.9

2.4

2.22

286

(3027008) Opiates [Presence] in Urine

125

1355

0.88

0.68

2.1

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

750

0.84

0.68

1.3

1.4

—

(3027944) Amphetamines [Presence] in Urine

123

1334

0.88

0.68

2.1

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

749

0.85

0.67

1.3

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

273

1.27

0.67

1.3

g/l

40.1

38.4

0.32

143

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

748

0.85

0.66

1.3

1.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

207

2178

0.91

0.66

2.0

2.1

mg/l

10.9

11.0

0.11

189

1996

(3034770) Mitochondria Ab [Titer] in Serum

212

2227

0.91

0.66

1.2

titre

372.9

1053.5

—

106

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

747

0.85

0.66

1.3

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2137

20020

1.03

0.65

2.2

2.3

mg/l

3.0

0.47

1756

17007

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

443

0.80

0.65

1.1

ratio

1.0

1.1

1.29

160

(3035933) Granulocytes/100 leukocytes in Blood

148

1.36

0.64

1.2

2.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

476

1.19

0.63

2.4

2.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

152

1314

1.11

0.63

1.2

nmol/l

0.1

0.3

1.58

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

630

0.84

0.63

1.1

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

441

0.81

0.63

1.2

1.5

promille

0.9

1.2

0.78

319

(3000475) Leukocytes [#/volume] in Synovial fluid

213

2230

0.92

0.62

1.9

1.6

e6/l

13146.6

11833.3

0.17

155

1605

(3043409) Potassium [Moles/volume] in Arterial blood

236

2088

1.09

0.62

3.8

4.0

mmol/l

3.8

0.27

221

1980

(4198724)

169

0.68

0.61

1.0

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

119

1017

1.13

0.61

1.1

125.7

124.1

0.17

106

904

(3016018) Differential panel - Cerebral spinal fluid

809

1.14

0.61

1.6

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

138

1190

1.12

0.61

1.1

—

(3020650) Glucose [Presence] in Urine

180

0.69

0.61

1.0

1.6

—

(3047189) Immunofixation for 24 hour Urine

200

1.30

0.61

1.4

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.66

0.61

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.66

0.61

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

1.66

0.61

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.59

0.0

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.59

0.0

5.5

—

357.4

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

738

0.86

0.59

1.5

1.4

—

3.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

446

1.19

0.58

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

798

0.87

0.57

1.1

1.2

—

41.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

188

1654

1.09

0.57

2.1

g/l

128.4

127.8

0.10

120

1191

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

139

1206

1.11

0.56

1.2

—

(3044941) Cell count panel - Synovial fluid

134

1425

0.90

0.56

1.7

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

169

1.31

0.56

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.55

1.4

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

623

5721

1.05

0.55

1.3

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

369

1.20

0.55

1.7

1.8

106.6

101.7

0.44

332

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

206

1826

1.09

0.54

1.5

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

115

991

1.12

0.54

2.2

2.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

186

0.72

0.54

1.2

1.4

nmol/l

91.9

129.6

—

122

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

294

0.78

0.53

2.8

2.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

218

0.75

0.53

1.0

u/ml

0.1

1.0

—

107

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

380

1.19

0.52

1.3

1.6

nmol/l

3.5

4.2

0.15

310

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

687

0.87

0.51

1.3

u/ml

0.9

1.2

0.16

322

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

337

3432

0.94

0.51

2.0

u/l

41.0

40.0

0.45

290

3025

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.39

0.51

3.1

1.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

119

1264

0.90

0.51

1.6

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

372

3380

1.06

0.50

2.3

2.6

0.7

0.81

355

3226

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

248

0.77

0.50

1.5

mmol/l

7.9

8.4

—

143

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

130

1.33

0.50

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

172

1521

1.09

0.49

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

406

0.83

0.49

1.1

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

670

1.13

0.49

3.7

—

(3025941) Bacteria identified in Stool by Culture

509

4672

1.05

0.48

1.2

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

182

1.27

0.48

1.0

1.3

mu/l

173.2

60.3

0.62

129

(3021788) Differential panel - Synovial fluid

162

1689

0.92

0.48

1.6

1.5

—

(3045414) Leukocytes [Presence] in Urine

409

4130

0.95

0.47

2.0

1.9

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

497

0.85

0.47

1.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

214

2205

0.93

0.47

1.2

titre

193.8

159.0

0.16

187

(40768797) Stomach Pathology biopsy report

1258

12410

0.97

0.47

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.37

0.47

1.1

1.2

ng/l

20.8

75.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.46

0.47

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

148

0.71

0.46

1.0

1.4

—

(4146454)

109

947

1.11

0.46

2.5

2.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

539

1.14

0.45

1.6

1.7

mmol/24h

6.6

5.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

147

0.72

0.45

1.1

111.5

112.2

0.02

141

(3020891) Body temperature

308

2796

1.06

0.45

4.1

4.4

—

(3029075) Extractable nuclear Ab panel - Serum

245

1.22

0.45

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.40

0.45

1.0

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

249

2247

1.07

0.44

3.9

4.8

—

(3000060) B lymphocytes [#/volume] in Blood

116

1.33

0.44

1.4

2.1

e6/l

393.3

142.3

—

(3012565) Volume of 24 hour Urine

334

1.18

0.44

1.8

1.7

1920.4

1890.3

0.06

296

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

237

2425

0.94

0.44

1.1

u/ml

6.8

8.3

0.24

239

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

202

1.24

0.44

2.2

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

202

1.24

0.44

2.2

2.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

221

0.78

0.43

1.3

1.4

31.5

39.5

—

152

(3017446) Testosterone [Moles/volume] in Serum or Plasma

335

1.18

0.43

1.4

1.3

nmol/l

0.8

1.3

2.71

265

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

125

0.69

0.43

2.7

1.9

umol/l

13.1

18.1

—

125

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

706

0.88

0.43

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

706

0.88

0.43

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

273

1.20

0.43

1.1

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

273

1.20

0.43

1.1

1.4

—

(4306422)

122

1072

1.09

0.43

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3325

31512

1.02

0.42

3.6

3.5

ng/l

32.1

56.1

1.46

2295

20548

(3039744) RNA polymerase III Ab [Units/volume] in Serum

0.65

0.42

1.0

—

4.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

0.65

0.42

1.0

u/ml

0.0

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

780

1.11

0.41

6.1

9.1

mmol/l

7.0

7.5

0.62

635

(40759836) Histone Ab [Presence] in Serum by Immunoblot

704

0.89

0.41

1.1

1.2

—

(3028433) Virus identified in Specimen by Culture

230

1.21

0.41

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

131

1157

1.09

0.41

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

195

1.23

0.41

1.1

1.4

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.41

0.0

1.0

—

0.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.41

0.0

1.1

—

(3017569) Oxygen content in Arterial blood

310

1.18

0.41

2.3

2.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

310

1.18

0.41

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

407

0.85

0.41

1.0

u/ml

0.6

0.05

(3028679) Herpes simplex virus Ab [Presence] in Serum

328

1.17

0.41

1.3

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

116.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

134

1395

0.92

0.40

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

608

1.12

0.40

1.6

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

3006

0.95

0.40

1.9

1.4

g/l

7.6

0.07

219

2166

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.46

0.40

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

205

1.22

0.40

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

711

0.89

0.39

1.1

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.39

0.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

710

0.89

0.39

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

710

0.89

0.39

1.1

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2221

21684

0.98

0.39

3.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

3001

0.95

0.38

1.9

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

297

3000

0.95

0.38

1.9

1.4

g/l

3.8

3.7

0.04

209

2088

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.35

0.38

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

163

0.77

0.37

1.0

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

279

2820

0.95

0.37

1.9

1.4

g/l

3.1

0.10

214

2135

(3034274) Bile acid [Moles/volume] in Serum --fasting

626

0.89

0.37

1.6

1.7

umol/l

8.0

7.5

0.06

447

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

139

1240

1.08

0.36

1.1

au/ml

8.7

17.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

103

1.31

0.36

1.4

2.2

—

(40757373) Influenza virus identified in Isolate

129

1.27

0.36

1.3

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

183

0.79

0.36

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

183

0.79

0.36

1.3

1.4

—

(3042733) HLA Ab [Presence] in Serum

151

0.76

0.36

4.8

4.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

586

5447

1.04

0.35

2.9

2.4

g/l

9.9

10.5

2.99

532

4954

(3039000) Anion gap in Blood

163

1467

1.07

0.34

5.1

5.6

mmol/l

10.3

11.1

2.57

152

1303

(3023183) Ammonium ion [Moles/volume] in Plasma

127

1133

1.08

0.34

2.7

2.5

umol/l

34.8

32.3

0.63

101

962

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

452

1.13

0.34

1.2

—

(3024928) Oxygen saturation in Venous blood

154

1384

1.07

0.34

2.1

3.0

—

(3018572) Chloride [Moles/volume] in Blood

163

1468

1.07

0.34

5.1

5.6

mmol/l

105.3

104.5

1.36

152

1304

(3044290) Cell count panel - Cerebral spinal fluid

153

1569

0.94

0.34

1.4

—

(4094501)

228

2309

0.95

0.34

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

353

1.14

0.33

1.6

1.4

pmol/l

16.4

15.6

0.46

296

(3045716) Anion gap in Serum or Plasma

344

1.15

0.33

3.5

2.4

mmol/l

9.3

8.8

0.37

248

(40762365) Oxygen content in Arterial blood by calculation

1.34

0.33

1.5

2.1

ml/dl

13.9

15.1

1.55

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

123

1098

1.08

0.33

1.2

u/ml

3.1

3.6

0.17

380

(3048879) Bone marrow aspiration report

157

1.22

0.33

2.6

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

157

1.22

0.33

1.5

1.6

—

(4015189)

233

0.82

0.33

2.1

2.7

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.69

0.33

2.0

1.9

mg/l

1.2

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

460

4263

1.04

0.33

1.8

1.5

g/l

1.3

0.23

416

3851

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.28

0.32

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

395

3941

0.96

0.32

1.5

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2138

20240

1.02

0.32

1.5

nmol/l

21.7

21.8

0.20

1750

16851

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

149

1.23

0.32

1.4

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

116

1036

1.08

0.31

1.1

1.2

—

(4211845)

465

1.12

0.31

4.2

3.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

320

1.14

0.30

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

539

1.11

0.30

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

9381

90271

0.97

0.29

25.1

18.2

g/l

129.9

132.6

90.96

9249

88631

(3014271) Vancomycin [Susceptibility]

440

1.11

0.29

3.1

3.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.22

0.28

1.4

1.5

—

(3010813) Leukocytes [#/volume] in Blood

9381

90264

0.97

0.28

25.0

18.2

e9/l

6.3

6.5

10.97

9109

87043

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

236

2371

0.95

0.28

1.9

1.4

g/l

37.7

37.8

0.02

198

1957

(3005033) Fetal Nuchal fold Thickness US

633

0.91

0.28

1.3

1.4

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.32

0.28

1.4

1.7

umol/l

69.9

48.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

642

0.91

0.27

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

282

2819

0.96

0.27

1.9

1.4

g/l

9.9

10.1

0.35

231

2295

(3022493) Free Hemoglobin [Mass/volume] in Plasma

251

1.15

0.27

1.1

4.0

mg/l

7356.4

68.1

0.48

162

(3047181) Lactate [Moles/volume] in Blood

235

2160

1.05

0.27

4.4

4.9

mmol/l

1.2

1.3

0.91

215

1897

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

309

0.87

0.27

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

551

0.91

0.27

1.0

1.1

iu/ml

5.5

9.4

—

106

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

196

0.83

0.26

1.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

109

980

1.07

0.26

1.1

1.2

u/ml

291.4

290.5

0.01

621

(3026361) Erythrocytes [#/volume] in Blood

9381

90255

0.97

0.26

25.0

18.1

e12/l

4.3

4.4

71.56

9102

87040

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.71

0.26

2.0

2.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

407

1.11

0.26

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

619

1.09

0.26

1.2

1.1

mmol/l

38.5

33.0

1.28

503

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

287

0.87

0.25

1.0

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

124

1263

0.94

0.25

1.1

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1729

16835

0.98

0.25

1.8

1.7

nmol/l

1138.6

1195.6

1.62

1225

12492

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

598

0.92

0.25

1.4

1.3

nmol/l

1.5

1.4

0.12

535

(3037556) Urate [Mass/volume] in Serum or Plasma

235

1.14

0.25

1.4

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

286

0.87

0.24

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

162

1635

0.95

0.24

1.7

mu/l

314.2

331.5

0.29

150

1454

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

120

1087

1.06

0.24

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

204

0.85

0.24

2.5

1.5

—

(3024731) MCV [Entitic volume]

9381

90246

0.98

0.24

24.9

18.1

91.7

91.1

28.17

9247

88588

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

255

0.87

0.24

1.2

1.1

105.6

114.6

0.79

221

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

326

0.88

0.24

2.7

2.0

umol/l

299.0

126.0

0.79

182

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

110

1.22

0.24

1.0

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.28

0.24

1.0

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

636

0.92

0.23

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

665

0.92

0.23

1.3

1.5

—

(1616796) Gas panel - Central venous blood

150

1371

1.05

0.23

3.2

3.3

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

633

1.08

0.23

1.5

1.3

titre

41.2

63.2

—

(3034426) Prothrombin time (PT)

223

0.86

0.22

1.1

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

180

1654

1.05

0.22

2.3

2.5

—

(3035941) MCH [Entitic mass]

9381

90238

0.98

0.22

24.9

18.1

30.3

30.2

9.28

9246

88581

(36660697) Celiac disease serology panel - Serum

731

7166

0.98

0.22

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

117

1063

1.06

0.22

1.2

u/ml

3.4

3.8

0.19

443

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

0.74

0.22

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1391

13179

1.02

0.21

1.4

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

6.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.21

0.0

1.0

—

80.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

645

1.07

0.21

1.5

1.3

titre

152.0

506.2

—

(44806071)

0.79

0.21

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

112

1.20

0.21

9.1

6.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

395

1.09

0.21

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

412

0.91

0.20

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.3

—

100.4

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.20

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

119

1086

1.05

0.20

1.2

1.3

pmol/l

501.3

287.2

0.44

848

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

271

0.89

0.20

1.2

g/l

0.3

0.94

224

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.25

0.20

1.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

109

0.79

0.20

1.4

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

837

0.94

0.20

1.9

1.4

e6/l

113887.5

119313.3

0.03

557

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

249

1.12

0.19

1.0

1.1

91.4

92.7

0.08

110

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.20

0.19

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

169

0.85

0.19

1.1

—

(3023419) Bacteria identified in Sputum by Culture

891

1.06

0.19

2.6

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

179

0.86

0.19

1.0

1.1

—

(3025315) Body weight

1.13

0.18

5.5

4.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

248

2457

0.97

0.18

1.9

iu/l

4.5

16.2

0.71

921

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

123

1.17

0.18

1.0

ug/l

93.7

77.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

384

3600

1.03

0.18

2.3

2.4

e6/l

0.3

0.00

377

3452

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

334

1.09

0.18

1.9

1.6

ug/l

0.4

0.02

208

(4212803)

1.16

0.17

1.0

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

242

1.11

0.17

1.0

1.1

98.9

95.3

0.17

111

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

177

0.87

0.17

1.5

2.6

mmol/l

6.6

7.2

—

110

(3004119) Hemoglobin [Mass/volume] in Venous blood

470

4422

1.02

0.17

2.6

3.1

g/l

124.0

127.9

4.27

462

4314

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.75

0.17

1.0

mmol/l

9.5

8.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.73

0.17

1.0

1.1

—

(3007461) Platelets [#/volume] in Blood

9380

90198

0.98

0.16

25.0

18.1

e9/l

259.7

262.6

4.23

9127

87314

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

396

0.92

0.16

2.9

2.4

u/ml

2272.7

785.6

0.48

388

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

161

1.13

0.16

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

402

1.08

0.15

1.8

—

(3045424) Erythrocytes [Presence] in Urine

150

1493

0.96

0.15

1.5

1.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

618

6033

0.98

0.15

2.4

au/ml

26.6

29.8

0.25

316

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

107

1.17

0.15

1.0

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

226

2232

0.97

0.15

2.8

1.5

ratio

2.1

1.4

0.49

182

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

124

0.85

0.14

1.0

1.2

u/ml

110.5

48.4

1.20

119

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

721

7022

0.99

0.14

2.7

2.8

ng/l

194.3

183.9

0.26

661

6403

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

155

1441

1.03

0.14

1.7

1.9

u/l

3871.2

3963.1

0.01

570

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

378

3703

0.98

0.14

1.1

u/ml

1.0

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

380

3579

1.02

0.14

3.0

mmol/l

25.6

25.7

0.34

371

3478

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

313

0.92

0.13

6.1

4.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

981

0.96

0.13

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

386

1.07

0.13

1.1

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

804

0.96

0.13

1.6

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.19

0.13

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

188

1756

1.03

0.13

1.2

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

312

1.08

0.13

1.1

ng/l

78.4

701.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

312

0.92

0.13

2.0

3.1

umol/l

26.8

27.5

0.11

241

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

112

0.86

0.12

1.1

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

753

0.96

0.12

1.6

u/ml

18.0

23.0

0.73

164

(3006653) Thiamine [Moles/volume] in Blood

350

0.93

0.12

1.2

1.3

nmol/l

139.1

132.6

0.31

350

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

174

1.10

0.12

1.2

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

128

1.13

0.11

8.8

6.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

165

1.11

0.11

5.2

2.4

—

(3024263) Appearance of Synovial fluid

436

1.06

0.11

1.9

1.7

—

(3000034) Microalbumin [Mass/volume] in Urine

761

0.96

0.11

2.4

2.8

mg/l

20.4

36.4

0.63

504

(3000330) Specific gravity of Urine by Test strip

482

4563

1.02

0.11

3.3

3.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

566

5508

0.99

0.11

1.3

au/ml

72.6

46.9

1.36

227

(3052592) Norovirus Ag [Presence] in Stool

141

0.89

0.11

1.2

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

871

1.04

0.11

1.6

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

259

1.08

0.10

2.9

2.0

umol/l

52.3

57.0

0.40

190

(3002619) Bacteria identified in Specimen by Culture

166

1.10

0.10

1.1

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

911

1.03

0.10

1.1

g/l

1.5

0.68

807

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.14

0.10

1.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

396

0.95

0.10

1.0

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

571

1.04

0.09

1.2

1.4

mmol/l

2.4

2.2

0.40

531

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.07

0.09

1.4

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.07

0.09

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.07

0.09

1.0

—

(3006462) Nitrate [Presence] in Urine

430

1.05

0.09

4.1

3.5

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

171

1608

1.02

0.09

2.5

2.8

mmol/l

25.8

25.5

0.39

144

1408

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

256

2500

0.98

0.08

2.1

1.5

g/l

0.7

0.4

0.65

212

2089

(40765089) Chromosome analysis panel - Blood by G-banded

1.07

0.08

1.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

1.03

0.08

1.0

1.3

—

17.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

215

1.07

0.08

21.8

26.7

ug/l

105.7

108.7

0.08

178

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.79

0.08

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.81

0.07

6.0

4.6

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.81

0.07

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

1.05

0.07

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.04

0.07

11.8

11.0

mmol/l

4.0

4.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.86

0.07

1.4

1.1

—

(3015183) Erythrocyte sedimentation rate

339

1.05

0.07

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.07

0.07

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

226

1.06

0.07

1.0

1.2

pmol/l

194.1

327.2

2.12

153

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

179

1.07

0.07

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.03

0.07

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

127

0.91

0.07

1.1

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.88

0.06

1.9

2.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.88

0.06

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

100

0.86

0.06

1.2

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

264

2504

1.01

0.06

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

0.92

0.06

1.3

1.2

—

(4133840)

156

0.92

0.06

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

208

1.06

0.06

1.1

1.0

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

237

2305

0.99

0.06

2.9

1.6

mg/l

39.8

39.3

0.03

183

1874

(3011985) Renin [Units/volume] in Plasma

124

1169

1.02

0.06

1.4

mu/l

84.4

50.2

1.02

110

1046

(3004451) EKG impression Narrative

360

1.04

0.06

1.3

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

370

0.96

0.05

1.1

1.2

58.3

58.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

209

2034

0.99

0.05

2.0

1.5

g/l

0.0

0.18

186

1830

(3051101) Glucose [Moles/volume] in Cord blood

165

0.93

0.05

5.9

5.6

—

(3014051) Protein [Presence] in Urine by Test strip

225

2135

1.01

0.05

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

206

2004

0.99

0.05

2.0

1.5

g/l

0.0

0.00

185

1822

(46235355) HIV 1 and 2 tests - Meaningful Use set

898

8580

1.01

0.05

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

194

0.94

0.05

1.0

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

225

2187

0.99

0.05

2.0

1.5

g/l

0.0

0.30

201

1975

(3011648) Oxygen content in Venous blood

513

1.03

0.05

1.5

2.1

9.8

10.8

0.99

513

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

518

5011

0.99

0.05

2.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

261

2480

1.01

0.05

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

264

2511

1.01

0.04

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

182

1.06

0.04

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

549

5303

0.99

0.04

2.1

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

202

0.95

0.04

29.5

32.1

ug/l

7.5

7.0

0.79

180

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

192

0.95

0.03

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

507

1.02

0.03

1.1

1.0

nmol/l

3.3

5.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

115

1090

1.01

0.03

1.1

u/ml

4.6

3.7

0.19

451

(3051387) C reactive protein [Mass/volume] in Capillary blood

187

1813

0.99

0.03

3.7

3.6

mg/l

28.5

22.8

1.03

109

1147

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

288

2785

0.99

0.03

1.7

mg/l

2.6

3.1

0.79

202

1980

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

491

0.98

0.03

1.3

1.5

u/l

4.4

5.4

1.90

413

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

193

1.05

0.03

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

481

0.98

0.03

1.1

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

240

2289

1.01

0.03

1.3

1.4

—

(3023410) Appearance of Cerebral spinal fluid

741

0.99

0.02

1.8

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

203

1.04

0.02

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

577

0.98

0.02

1.1

1.0

mg/l

310.7

296.8

0.85

511

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

720

1.01

0.02

1.6

1.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

194

1.04

0.02

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

2121

1.01

0.01

1.1

1.2

—

(3020491) Glucose [Moles/volume] in Blood

565

0.99

0.01

1.3

1.9

mmol/l

6.5

6.9

0.56

386

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

611

5856

1.00

0.01

1.8

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

120

1161

0.99

0.01

1.2

nmol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4948

47510

1.00

0.01

2.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

121

0.95

0.00

1.7

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

238

2293

1.00

0.00

2.9

1.6

mg/l

41.0

35.3

0.27

187

1857

(40760888) Immunoglobulin light chains.free panel - Serum

173

1668

1.00

0.00

3.0

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

159

0.97

0.00

1.2

1.1

—

(3024932) HLA-DR beta [Type]

137

0.98

0.00

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

214

0.99

0.00

1.3

1.4

ng/l

71.7

92.9

0.97

214

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

117

0.99

0.00

2.1

2.8

u/field

0.8

0.02

117

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

126

0.99

0.00

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

167

0.98

0.00

1.1

—

(3024471) HLA-A [Type]

140

1.03

0.00

1.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

314

1.01

0.00

1.1

100.7

95.3

0.45

236

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

115

1.00

0.00

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

255

1.02

0.00

1.1

1.2

22.8

20.0

—

(4268621)

724

0.99

0.00

2.3

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

168

0.97

0.00

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

151

1.02

0.00

1.9

1.6

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.90

0.00

4.6

7.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013466) aPTT in Blood by Coagulation assay

1.00

0.00

1.0

1.1

34.0

36.7

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.99

0.00

1.1

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

175.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

0.0

1.0

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

0.91

0.00

2.6

2.8

—

34.9

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.99

0.00

1.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.99

0.00

2.4

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.2

—

246.9

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.89

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BREAST_ERNEG_EXALLC – Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

GWS hits: 18

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers) (C3_BREAST_ERNEG_EXALLC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints